<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">786758</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2021.786758</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>The Tongue Squamous Carcinoma Cell Line Cal27 Primarily Employs Integrin &#x3b1;6&#x3b2;4-Containing Type II Hemidesmosomes for Adhesion Which Contribute to Anticancer Drug Sensitivity</article-title>
<alt-title alt-title-type="left-running-head">Tadijan et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Type II Hemidesmosome Adhesion</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Tadijan</surname>
<given-names>Ana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/862678/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Humphries</surname>
<given-names>Jonathan D.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="fn" rid="fn1">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/277537/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Samar&#x17e;ija</surname>
<given-names>Ivana</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/863660/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stojanovi&#x107;</surname>
<given-names>Nikolina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/866780/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zha</surname>
<given-names>Junzhe</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>&#x10c;uljak</surname>
<given-names>Kristina</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tomi&#x107;</surname>
<given-names>Marija</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1499929/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Parad&#x17e;ik</surname>
<given-names>Mladen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/862804/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nesti&#x107;</surname>
<given-names>Davor</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/862751/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Heemin</given-names>
</name>
<xref ref-type="aff" rid="aff6">
<sup>6</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Humphries</surname>
<given-names>Martin J.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/866598/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Ambriovi&#x107;-Ristov</surname>
<given-names>Andreja</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/862598/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Laboratory for Cell Biology and Signalling, Division of Molecular Biology, Ru&#x111;er Bo&#x161;kovi&#x107; Institute, <addr-line>Zagreb</addr-line>, <country>Croatia</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>Laboratory for Protein Dynamics, Division of Molecular Medicine, Ru&#x111;er Bo&#x161;kovi&#x107; Institute, <addr-line>Zagreb</addr-line>, <country>Croatia</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester, <addr-line>Manchester</addr-line>, <country>United&#x20;Kingdom</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Department of Life Sciences, Manchester Metropolitan University, <addr-line>Manchester</addr-line>, <country>United&#x20;Kingdom</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>Laboratory for Epigenomics, Division of Molecular Medicine, Ru&#x111;er Bo&#x161;kovi&#x107; Institute, <addr-line>Zagreb</addr-line>, <country>Croatia</country>
</aff>
<aff id="aff6">
<label>
<sup>6</sup>
</label>Department of Materials Science and Engineering, Korea University, <addr-line>Seoul</addr-line>, <country>South Korea</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/601326/overview">Claudia Tanja Mierke</ext-link>, Leipzig University, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/505636/overview">Heloisa Sobreiro Selistre-de-Araujo</ext-link>, Biological Sciences, Federal University of S&#xe3;o Carlos, Brazil</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/650094/overview">Anne Elizabeth Cress</ext-link>, University of Arizona, United&#x20;States</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Andreja Ambriovi&#x107;-Ristov, <email>Andreja.Ambriovic.Ristov@irb.hr</email>
</corresp>
<fn fn-type="equal" id="fn1">
<label>
<sup>&#x2020;</sup>
</label>
<p>These authors share first authorship</p>
</fn>
<fn fn-type="other">
<p>This article was submitted to Cell Adhesion and Migration, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>786758</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>09</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>11</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Tadijan, Humphries, Samar&#x17e;ija, Stojanovi&#x107;, Zha, &#x10c;uljak, Tomi&#x107;, Parad&#x17e;ik, Nesti&#x107;, Kang, Humphries and Ambriovi&#x107;-Ristov.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Tadijan, Humphries, Samar&#x17e;ija, Stojanovi&#x107;, Zha, &#x10c;uljak, Tomi&#x107;, Parad&#x17e;ik, Nesti&#x107;, Kang, Humphries and Ambriovi&#x107;-Ristov</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Integrins are heterodimeric cell surface glycoproteins used by cells to bind to the extracellular matrix (ECM) and regulate tumor cell proliferation, migration and survival. A causative relationship between integrin expression and resistance to anticancer drugs has been demonstrated in different tumors, including head and neck squamous cell carcinoma. Using a Cal27 tongue squamous cell carcinoma model, we have previously demonstrated that <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 confers resistance to several anticancer drugs (cisplatin, mitomycin C and doxorubicin) through a mechanism involving downregulation of active Src, increased cell migration and invasion. In the integrin &#x3b1;V&#x3b2;3 expressing Cal27-derived cell clone 2B1, &#x3b1;V&#x3b2;5 expression was also increased, but unrelated to drug resistance. To identify the integrin adhesion complex (IAC) components that contribute to the changes in Cal27 and 2B1 cell adhesion and anticancer drug resistance, we isolated IACs from both cell lines. Mass spectrometry (MS)-based proteomics analysis indicated that both cell lines preferentially, but not exclusively, use integrin &#x3b1;6&#x3b2;4, which is classically found in hemidesmosomes. The anticancer drug resistant cell clone 2B1 demonstrated an increased level of &#x3b1;6&#x3b2;4 accompanied with increased deposition of a laminin-332-containing ECM. Immunofluorescence and electron microscopy demonstrated the formation of type II hemidesmosomes by both cell types. Furthermore, suppression of &#x3b1;6&#x3b2;4 expression in both lines conferred resistance to anticancer drugs through a mechanism independent of &#x3b1;V&#x3b2;3, which implies that the cell clone 2B1 would have been even more resistant had the upregulation of &#x3b1;6&#x3b2;4 not occurred. Taken together, our results identify a key role for &#x3b1;6&#x3b2;4-containing type II hemidesmosomes in regulating anticancer drug sensitivity.</p>
</abstract>
<kwd-group>
<kwd>adhesome</kwd>
<kwd>hemidesmosome</kwd>
<kwd>integrin alpha 6 beta 4</kwd>
<kwd>laminin-332</kwd>
<kwd>integrin alpha v beta 3</kwd>
<kwd>integrin crosstalk</kwd>
<kwd>anticancer drug sensitivity</kwd>
<kwd>keratins 5/14</kwd>
</kwd-group>
<contract-num rid="cn001">IP-2019-04-1577 IP-2013-11-2465</contract-num>
<contract-num rid="cn002">C13329/A21671</contract-num>
<contract-num rid="cn003">CA15214</contract-num>
<contract-sponsor id="cn001">Hrvatska Zaklada za Znanost<named-content content-type="fundref-id">10.13039/501100004488</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Cancer Research UK<named-content content-type="fundref-id">10.13039/501100000289</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">European Cooperation in Science and Technology<named-content content-type="fundref-id">10.13039/501100000921</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Integrins are transmembrane cell adhesion receptors consisting of &#x3b1; and &#x3b2; subunits. Eighteen &#x3b1; and eight &#x3b2; subunits are present in mammals, which can assemble to form 24 different dimers (<xref ref-type="bibr" rid="B42">Hynes, 2002</xref>). During tumorigenesis, the integrin repertoire is often switched to enable proliferation, survival, migration and invasion (<xref ref-type="bibr" rid="B20">Desgrosellier and Cheresh, 2010</xref>; <xref ref-type="bibr" rid="B17">Cooper and Giancotti, 2019</xref>; <xref ref-type="bibr" rid="B70">Samar&#x17e;ija et&#x20;al., 2020</xref>). Cell adhesion is also associated with resistance to anticancer drugs (<xref ref-type="bibr" rid="B19">Damiano et&#x20;al., 1999</xref>; <xref ref-type="bibr" rid="B20">Desgrosellier and Cheresh, 2010</xref>; <xref ref-type="bibr" rid="B72">Seguin et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B21">Dickreuter and Cordes, 2017</xref>). In head and neck squamous cell carcinoma (HNSCC), expression of several integrins, including &#x3b1;V&#x3b2;3 and/or &#x3b1;V&#x3b2;5, is increased compared to normal epithelium (<xref ref-type="bibr" rid="B1">Ahmedah et&#x20;al., 2017</xref>). Changes in integrin expression have been observed in clones of human laryngeal carcinoma HEp2 cells produced by acute (<xref ref-type="bibr" rid="B3">Ambriovi&#x107;-Ristov et&#x20;al., 2004</xref>) or chronic (<xref ref-type="bibr" rid="B55">Majhen et&#x20;al., 2014</xref>) exposure to cisplatin (cDDP), respectively. A causative relationship between <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 and cDDP, mitomycin C (MMC) or doxorubicin (DOX) resistance through increased total amount of glutathione, which conferred survival due to better elimination of reactive oxygen species induced by anticancer drugs, has been demonstrated in the same model of HEp2 cells (<xref ref-type="bibr" rid="B10">Brozovi&#x107; et&#x20;al., 2008</xref>). Similar effects have been reported in the HNSCC model Cal27 (tongue squamous carcinoma cells), although the mechanism of cDDP, MMC and DOX resistance was not the same, i.e.,&#x20;<italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 conferred anticancer drug resistance through deactivation of Src (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). De novo expression of integrin &#x3b1;V&#x3b2;3 in both cell models resulted in increased migration and invasion (<xref ref-type="bibr" rid="B10">Brozovi&#x107; et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>).</p>
<p>Integrins bind to ECM proteins and, upon clustering, trigger signaling pathways through recruitment of multimolecular integrin adhesion complexes (IACs) to their cytoplasmic tails and through association with the cell cytoskeleton (<xref ref-type="bibr" rid="B87">Winograd-Katz et&#x20;al., 2014</xref>). Integrins, together with associated IAC components, have been termed the adhesome (<xref ref-type="bibr" rid="B92">Zaidel-Bar et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B47">Kuo et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B71">Schiller et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B11">Byron et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B46">Jones et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B13">Chastney et&#x20;al., 2020</xref>). Functional and morphological analyses have defined several major forms of IACs, including focal complexes, focal adhesions (FAs), fibrillar adhesions, hemidesmosomes (HDs) and reticular adhesions, also called clathrin lattices or plaques (<xref ref-type="bibr" rid="B94">Zuidema et&#x20;al., 2020</xref>). FAs are strongly associated with actin filaments that link neighboring structures (<xref ref-type="bibr" rid="B2">Albiges-Rizo et&#x20;al., 2009</xref>). Fibrillar adhesions are long, stable structures that run parallel to bundles of fibronectin (FN) <italic>in vivo</italic> and are highly enriched in tensin and &#x3b1;5&#x3b2;1 integrin (<xref ref-type="bibr" rid="B93">Zamir et&#x20;al., 1999</xref>), while reticular adhesions are formed by integrin &#x3b1;V&#x3b2;5 in the absence of both talin and F-actin (<xref ref-type="bibr" rid="B53">Lock et&#x20;al., 2018</xref>, <xref ref-type="bibr" rid="B52">2019</xref>). HDs facilitate stable adhesion of basal epithelial cells to the underlying basement membrane (BM) via integrin <italic>&#x3b1;</italic>6<italic>&#x3b2;</italic>4 and are associated with keratin intermediate filaments. The classical type I HDs consist of the integrin <italic>&#x3b1;</italic>6<italic>&#x3b2;</italic>4, plectin (PLEC; isoform 1a), tetraspanin CD151, BP230 (known as dystonin or BPAG1-e) and BP180 (known as BPAG2 or collagen XVII) (<xref ref-type="bibr" rid="B81">Walko et&#x20;al., 2015</xref>), while type II HDs consist of only <italic>&#x3b1;</italic>6<italic>&#x3b2;</italic>4 and plectin (<xref ref-type="bibr" rid="B80">Uematsu et&#x20;al., 1994</xref>; <xref ref-type="bibr" rid="B26">Fontao et&#x20;al., 1999</xref>).</p>
<p>The ventral IACs from 2D cell cultures have been isolated using several protocols (<xref ref-type="bibr" rid="B40">Humphries et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B47">Kuo et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B71">Schiller et&#x20;al., 2011</xref>; <xref ref-type="bibr" rid="B46">Jones et&#x20;al., 2015</xref>) and analyzed by MS. However, most IAC preparations have been isolated from cells seeded on FN, which led to the definition of an FN-induced meta adhesome composed of over 2,400 proteins. Subsequent reduction defined 60 core proteins, termed the consensus adhesome (<xref ref-type="bibr" rid="B87">Winograd-Katz et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B37">Horton et&#x20;al., 2015</xref>). There is less information on the adhesome of cells cultured on dishes without prior coating with ECM proteins. <xref ref-type="bibr" rid="B53">Lock et&#x20;al. (2018)</xref> analyzed IACs of osteosarcoma U2OS cells cultured for 72&#xa0;h and demonstrated that the most abundant integrin subunits were &#x3b1;V and &#x3b2;5, with much lower levels of &#x3b2;1, &#x3b2;3, &#x3b2;8, &#x3b1;5 and &#x3b1;3. Using a similar approach, we have recently analyzed the adhesome of the melanoma cell line MDA-MB-435S and found that these cells preferentially use integrin &#x3b1;V&#x3b2;5 for adhesion during <italic>in&#x20;vitro</italic> cultivation, forming either FAs or RAs (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>). MS-based IAC analysis has an advantage over other adhesome analysis methods because it enables the simultaneous identification of ECM proteins secreted by cells and may therefore enable the identification of integrin-ECM interactions.</p>
<p>We have previously demonstrated that <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 in Cal27 cells confers resistance to cDDP, MMC and DOX through Src deactivation and contributes to increased migration and invasion. De novo expression of integrin &#x3b1;V&#x3b2;3 caused an integrin crosstalk event, i.e.,&#x20;upregulation of integrin &#x3b1;V&#x3b2;5 expression through increased production of integrin &#x3b2;5 mRNA. Integrin &#x3b1;V&#x3b2;5 was not involved in the mechanism of anticancer drug resistance (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). To extend our understanding of the adhesion components and complexes whose differential expression contributes to the observed changes in adhesion and anticancer drug resistance, we isolated IACs from Cal27 cells and the Cal27-derived cell clone 2B1, with <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 and increased levels of &#x3b1;V&#x3b2;5. MS analysis of isolated IACs showed that both cell lines preferentially, but not exclusively, use integrin &#x3b1;6&#x3b2;4. We showed that integrin &#x3b1;6&#x3b2;4 in Cal27 and 2B1 cells form type II HDs consisting of integrin &#x3b1;6&#x3b2;4 and PLEC. Moreover, in 2B1 cells, MS analysis revealed increased abundance of integrin &#x3b1;6&#x3b2;4 and PLEC, but decreased abundance of keratins KRT-5 and KRT-14 suggesting that these type II HDs have reduced anchorage to keratins. In addition, 2B1 cells demonstrated increased expression of BM components, i.e.,&#x20;integrin &#x3b1;6&#x3b2;4 receptor laminin-332 and collagen VII (COL7A1) which supports our conclusion of increased anchorage of cells via type II HDs. Finally, we showed that integrin &#x3b2;4 knockdown in Cal27 and 2B1 cells decreased expression of the integrin &#x3b1;6&#x3b2;4 heterodimer on the cell surface and conferred resistance to cDDP, MMC and DOX, thus showing an independent resistance mechanism than the one triggered by <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3. This work contributes to the understanding of both the close connection between FAs and HDs in HNSCC cells and to the diversity of HD composition able to regulate sensitivity to anticancer&#x20;drugs.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Cells</title>
<p>The human tongue squamous cell carcinoma cell line Cal27 was obtained from the American Type Culture Collection (ATCC, United&#x20;States). Integrin &#x3b1;V&#x3b2;3-expressing cell clone 2B1 was established from Cal27 cells by stable transfection with the pcDNA&#x3b2;3 containing integrin subunit &#x3b2;3 cDNA (kindly provided by E. H. Danen, Leiden, Netherlands) as described (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). Cells were grown in Dulbecco&#x2019;s modified Eagle&#x2019;s medium (DMEM; Invitrogen, United&#x20;States) supplemented with 10% (v/v) fetal bovine serum (FBS; Invitrogen, United&#x20;States) at 37&#xb0;C with 5% CO<sub>2</sub> (v/v) in a humidified atmosphere.</p>
</sec>
<sec id="s2-2">
<title>Survival Analysis</title>
<p>The anticancer drugs cDDP, MMC and DOX (Sigma-Aldrich, Germany) were dissolved in water and stored at &#x2212;20&#xb0;C. MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, Millipore, United&#x20;States) assay was used to determine the sensitivity of cells to anticancer drugs. Briefly, cells were treated 24&#xa0;h after seeding in 96-well tissue culture plates (5 &#xd7; 10<sup>3</sup>&#xa0;cells/well). Cells previously transfected with siRNA were seeded 24&#xa0;h upon transfection. Seventy-two hours upon anticancer drug exposure, the absorbance of MTT-formazan product dissolved in DMSO, which is proportional to the number of viable cells, was measured with a microplate reader (Awareness Technology, Inc., United&#x20;States) at 600&#xa0;nm.</p>
</sec>
<sec id="s2-3">
<title>siRNA Transfection</title>
<p>For transient siRNA transfection experiments, cells were transfected with 25&#xa0;nM siRNA specific for integrin subunit &#x3b2;4 (target sequence: GCG&#x200b;ACT&#x200b;ACA&#x200b;CTA&#x200b;TTG&#x200b;GAT&#x200b;T, Sigma, Germany) by Lipofectamine RNAiMax (Thermo Fisher Scientific, United States). Transfection efficacy was validated by sodium dodecyl sulphate-polyacrylamide-gel electrophoresis (SDS-PAGE) and western blot (WB) using integrin subunit &#x3b2;4-specific antibody and matching, labelled secondary antibodies (listed in <xref ref-type="sec" rid="s10">Supplementary Table&#x20;S1</xref>).</p>
</sec>
<sec id="s2-4">
<title>Immunofluorescence and Confocal Microscopy</title>
<p>Cal27 and 2B1 cells were plated on coverslips at density of 3.5 &#xd7; 10<sup>4</sup> cells per well in a 24-well plate. After 48&#xa0;h, cells were fixed with 4% (w/v) paraformaldehyde, permeabilized with 0.1% (v/v) Triton X-100, and the immunostaining was performed with the appropriate antibodies for 1&#xa0;h, followed by incubation with conjugated secondary antibodies for 1&#xa0;h. All antibodies are listed in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. Cells were mounted with DAPI Fluoromount-G (SouthernBiotech, United&#x20;States). Fluorescence and respective IRM z-stack images (starting from the cell ventral surface) were acquired using an inverted confocal microscope (Leica TCS SP8 X, Leica Microsystems, Germany) with the HC PL APOCS2 63&#x20;&#xd7;/1.40&#x20;oil-immersion objective, zoom set at &#xd7;2.15. LAS X 3.1.1 (Leica Microsystems, Germany) software was used to analyze the images.</p>
</sec>
<sec id="s2-5">
<title>Isolation of IACs, Sample Preparation for MS and Data Analysis</title>
<p>Integrin adhesion complexes were isolated as previously described (<xref ref-type="bibr" rid="B46">Jones et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>). For each cell line, five biological replicates were analyzed. In short, cells (1 &#xd7; 10<sup>6</sup> for Cal27 and 9,4 &#xd7; 10<sup>5</sup> for 2B1) were plated on 10&#xa0;cm diameter cell culture dishes (at least six dishes per cell line) and after 72&#xa0;h washed with DMEM-HEPES and incubated with Wang and Richard&#x2019;s reagent for 10&#xa0;min (6&#xa0;mM DTBP, Thermo Fisher Scientific, United&#x20;States). DTBP was quenched by 0.03&#xa0;M Tris-HCl (pH 8) and cells were lysed using modified RIPA buffer (50&#xa0;mM Tris-HCl, pH 7.6; 150&#xa0;mM NaCl; 5&#xa0;mM disodium EDTA, pH 8; 1% (w/v) Triton X-100, 2.5% (w/v) SDS, 1% (w/v) sodium deoxycholate). Cell bodies were removed by high-pressure washing and remaining adhesion complex components were collected by scraping into the adhesion recovery solution (125&#xa0;mM Tris-HCl, pH 6.8; 1% (w/v) SDS; 150&#xa0;mM dithiothreitol). Isolated IACs were acetone precipitated and processed for either MS or WB analysis. For MS analysis, samples were prepared using in-gel trypsin digestion (<xref ref-type="bibr" rid="B46">Jones et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>), and analyzed using a modified version of the LC-MS/MS method, as previously described (<xref ref-type="bibr" rid="B37">Horton et&#x20;al., 2015</xref>). Briefly, an UltiMateR 3000 Rapid Separation LC (RSLC, United&#x20;States) coupled to an Orbitrap Elite mass spectrometer (Thermo Fisher Scientific, United&#x20;States) with electrospray ionization was used. Peptide mixtures were eluted for 44&#xa0;min using a gradient containing 92% of solution A (0.1% formic acid in water) and 8% up to 33% of solution B (0.1% formic acid in acetonitrile). Solvent flow was set to 300&#xa0;nl per minute. To identify proteins, data were searched against the human Uniprot database (version 2018_01) using Mascot (Matrix science, version 2.5.1). Fragment ion tolerance was set to 0.50&#xa0;Da and parent ion tolerance was 5 PPM. Protein identifications were further refined using Scaffold (Proteome software). Protein (99%) and peptide (90%) probabilities were assigned using the Protein Prophet&#x20;algorithm (<xref ref-type="bibr" rid="B60">Nesvizhskii et&#x20;al., 2003</xref>) as incorporated by Scaffold including a minimum of four spectral counts per protein. Spectral counts were used as a measure of protein abundance.</p>
</sec>
<sec id="s2-6">
<title>Protein-Protein Interaction (PPI) Network Analysis and Functional Enrichment Analysis</title>
<p>A protein&#x2013;protein interaction network of the proteins identified with a minimum of four spectral counts in at least three out of five biological replicates was constructed using STRING (v. 11.0, medium confidence of minimum required interaction score &#x3d; 0.40) (<xref ref-type="bibr" rid="B76">Szklarczyk et&#x20;al., 2019</xref>) and visualized with Cytoscape (version 3.7.1) (<xref ref-type="bibr" rid="B73">Shannon et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B22">Doncheva et&#x20;al., 2019</xref>). Proteins were manually assigned to functional groups using the Uniprot database (<xref ref-type="bibr" rid="B4">Apweiler et&#x20;al., 2004</xref>). For functional annotation and enrichment calculation, Database for annotation, visualization and integrated discovery (DAVID), version 6.8 (<xref ref-type="bibr" rid="B38">Huang et&#x20;al., 2009a</xref>; <xref ref-type="bibr" rid="B39">2009b</xref>) was used by utilizing DAVID_CC subontology list (Benjamini&#x2013;Hochberg corrected <italic>p</italic>-value &#x3c; 0.05, EASE score &#x3c; 0.1, at least four identified proteins). To visualize the enrichment, REViGO tool was used (with allowed similarity: small (0.5), semantic similarity measure to use: Resnik-normalized) (<xref ref-type="bibr" rid="B75">Supek et&#x20;al., 2011</xref>).</p>
</sec>
<sec id="s2-7">
<title>Transmission Electron Microscopy</title>
<p>Cal27 and 2B1 cells were grown on Aclar film (Agar Scientific Ltd.) for 7&#xa0;days in culture medium and fixed with 4% (v/v) formaldehyde plus 2.5% (v/v) glutaraldehyde in 0.1&#xa0;M HEPES buffer (pH 7.2). Subsequently samples were post-fixed with 1% (w/v) osmium tetroxide and 1.5% (w/v) potassium ferricyanide in 0.1&#xa0;M cacodylate buffer (pH 7.2) for 1&#xa0;h, then 1% (w/v) tannic acid in 0.1&#xa0;M cacodylate buffer (pH 7.2) for 1&#xa0;h and finally in 1% (w/v) uranyl acetate in distilled water for 1&#xa0;h. Samples were then dehydrated in an ethanol series infiltrated with TAAB Low Viscosity resin and polymerized for 24&#xa0;h at 60&#xb0;C as thin layers on Alcar sheets. After polymerization Aclar sheets were peeled off and layers of polymerized resin with cells were re-embedded with the same resin as stacks. Sections were cut with a Reichert Ultracut ultramicrotome and observed with a FEI Tecnai 12 Biotwin microscope at 100kV accelerating voltage. Images were taken with a Gatan Orius SC1000 CCD camera.</p>
</sec>
<sec id="s2-8">
<title>SDS-PAGE and Western Blot</title>
<p>Total cell lysates were obtained by lysing 1.2 &#xd7; 10<sup>6</sup> cells in 200&#xa0;&#x3bc;l RIPA buffer (Thermo Fisher Scientific, United&#x20;States), mixed with 5&#x20;&#xd7; Laemmli loading buffer (125&#xa0;mM Tris-HCl (pH 6.8), 25% (w/v) glycerol, 10% (w/v) SDS, 0.01% (w/v) bromophenol blue, 20% (v/v) 2-mercaptoethanol) to reach a final 1&#xd7; concentration and heated for 5&#xa0;min at 96&#xb0;C. Isolated IACs from at least six 10&#xa0;cm diameter culture dishes were dissolved in 2&#xd7; Laemmli loading buffer and heated for 20&#xa0;min at 70&#xb0;C. Total cell lysates or isolated IACs were analyzed by SDS-PAGE and WB. Isolated IACs were loaded onto gradient pre-cast gels (Biorad, United&#x20;States), separated with SDS-PAGE and transferred to a nitrocellulose membrane (Amersham, Germany). The membrane was blocked in 5% (w/v) non-fat dry milk, and incubated with the appropriate antibodies, followed by incubation with horseradish peroxidase coupled secondary antibody. All antibodies are listed in <xref ref-type="sec" rid="s10">Supplementary Table S1</xref>. Detection was performed using chemiluminescence (GE Healthcare) and visualized using iBright CL1000 (Thermo Fisher Scientific, United&#x20;States) or Uvitec Alliance Q9 mini (BioSPX b.v., Netherlands).</p>
</sec>
<sec id="s2-9">
<title>Statistical Analysis</title>
<p>MTT experiments were repeated at least three times, expressed as mean&#x20;&#xb1; standard deviation (SD) and analyzed by related-measure two-way analysis of variance (ANOVA) with Bonferroni posttest in GraphPad Prism v8.0 (GraphPad Software, United&#x20;States) to assess significance. QSpec Spectral counter tool was used for MS data to measure the significance of differentially identified proteins in 2B1 versus Cal27 (<xref ref-type="bibr" rid="B14">Choi et&#x20;al., 2008</xref>, <xref ref-type="bibr" rid="B15">2015</xref>) and GraphPad Prism v. 8 was used for visualization.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<sec id="s3-1">
<title>Cal27 Cells Primarily Utilize Integrin &#x3b1;6&#x3b2;4 for Adhesion</title>
<p>To define the adhesome composition in Cal27 and Cal27-derived 2B1 cells with <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>) we first optimized the IAC isolation and defined the adhesome for the Cal27 cell line. IACs were isolated from cells in long-term culture (72&#xa0;h), without prior coating of the cell culture dish with ECM proteins (<xref ref-type="bibr" rid="B46">Jones et&#x20;al., 2015</xref>). This approach was selected because it enables the analysis of IAC proteins as well as cell-secreted ECM proteins, as shown recently (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>). The optimal crosslinking duration of 10&#xa0;min was selected based on WB analysis of the marker IAC components, focal adhesion kinase (FAK), talin 1 (TLN1), integrin linked kinase (ILK) and paxillin (<xref ref-type="bibr" rid="B37">Horton et&#x20;al., 2015</xref>) from the isolated IACs (<xref ref-type="sec" rid="s10">Supplementary Figure&#x20;S1</xref>).</p>
<p>MS analysis of the Cal27 IACs detected 120 proteins with at least four spectral counts in minimum three out of five analyzed replicates (<xref ref-type="sec" rid="s10">Supplementary Table S2.1</xref>), 68 of which were in the meta adhesome (<xref ref-type="bibr" rid="B37">Horton et&#x20;al., 2015</xref>). The only integrin subunits identified were &#x3b1;6 (ITGA6) and &#x3b2;4 (ITGB4), indicating that Cal27 in cell culture primarily utilize &#x3b1;6&#x3b2;4 for adhesion. Classically, &#x3b1;6&#x3b2;4 forms HDs, which are multiprotein complexes that facilitate the stable adhesion of basal epithelial cells to the underlying BM. The extracellular region of &#x3b1;6&#x3b2;4 binds to laminin ligands, in particular the epithelial BM-specific variant laminin-332 (<xref ref-type="bibr" rid="B6">Aumailley et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B81">Walko et&#x20;al., 2015</xref>). Consistent with this, the Cal27 IAC preparations contained all three chains of laminin-332 (laminin subunit &#x3b1;3 (LAMA3); laminin subunit &#x3b2;3 (LAMB3) and laminin subunit &#x3b3;2 (LAMC2)) (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Mass spectrometry analysis of IACs isolated from Cal27 cells. <bold>(A)</bold> Protein&#x2013;protein interaction network of proteins identified in IACs isolated from Cal27 cells. Shapes represent proteins identified via MS and are labelled with gene symbols and manually grouped and assigned color according to their functional group, as indicated on the left. Only proteins identified with a minimal number of four spectral counts in at least three out of five analyzed biological replicates, FDR &#x3c; 5%, probability for protein identification &#x2265; 99.9% were visualized. The network was generated with Cytoscape 3.7.2. <bold>(B)</bold> IACs isolated from Cal27 were enriched with proteins connected to the membrane, cytoskeleton and ECM components. Proteins from <bold>(A)</bold> were assigned to functional groups using the DAVID GO database (GOTERM_CC_DIRECT) and visualized using the REViGO tool, where <italic>p</italic>-values related to GO terms of cellular components were represented by the color bar and size of the circle. Statistically significant GO terms (<italic>p</italic>&#x20;&#x3e; 0.05) are presented.</p>
</caption>
<graphic xlink:href="fcell-09-786758-g001.tif"/>
</fig>
<p>To further analyze the dataset, gene ontology (GO) enrichment analysis was performed on proteins identified in IACs isolated from Cal27 cells. A significant enrichment of GO terms related to extracellular exosome, cell-cell adherens junctions, ECM, membrane, intermediate filament and intracellular ribonucleoprotein complex was observed. Other GO terms such as ribosome and actin cytoskeleton were less well represented (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref> and <xref ref-type="sec" rid="s10">Supplementary Table S2.2</xref>). Therefore, the GO analysis supports the successful isolation of IACs from Cal27&#x20;cells.</p>
<p>Our previously published data showed that Cal27 cells express integrin &#x3b2;1, &#x3b2;5, &#x3b2;6 and &#x3b1;V mRNAs, cell surface &#x3b1;V&#x3b2;5, and adhere to vitronectin (VTN) and FN (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). Therefore, we expected that the composition of ECM proteins secreted by Cal27 cells reflects this integrin profile. We identified several ECM components, including established integrin ligands such as VTN, tenascin C (TNC) and cysteine-rich 61 (CYR61) (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). VTN is recognized by &#x3b1;V&#x3b2;1, &#x3b1;V&#x3b2;3, &#x3b1;V&#x3b2;5 and &#x3b1;IIb&#x3b2;3 (<xref ref-type="bibr" rid="B24">Felding-Habermann and Cheresh, 1993</xref>), TNC by &#x3b1;V&#x3b2;1, &#x3b1;V&#x3b2;3, &#x3b1;V&#x3b2;6, &#x3b1;2&#x3b2;1, &#x3b1;9&#x3b2;6 and &#x3b1;8&#x3b2;1 (<xref ref-type="bibr" rid="B58">Midwood et&#x20;al., 2016</xref>) and CYR61 by &#x3b1;V&#x3b2;3 and &#x3b1;V&#x3b2;5 (<xref ref-type="bibr" rid="B49">Lau, 2016</xref>). We also identified annexins A1 and 2 (ANXA1/2), for which both cellular and extracellular localizations have been demonstrated (<xref ref-type="bibr" rid="B82">Wang and Lin, 2014</xref>; <xref ref-type="bibr" rid="B9">Boudhraa et&#x20;al., 2016</xref>), and transforming growth factor beta induced (TGFBI) which connects various ECM components, and interacts with several integrins including &#x3b1;1&#x3b2;1, &#x3b1;3&#x3b2;1, &#x3b1;V&#x3b2;3, and &#x3b1;V&#x3b2;5 (<xref ref-type="bibr" rid="B84">Ween et&#x20;al., 2012</xref>). We also detected caveolin-1 (CAV1), a structural protein of caveolae/lipid rafts involved in integrin-dependent signaling (<xref ref-type="bibr" rid="B23">Echarri and Del Pozo, 2006</xref>), and chloride intracellular channel 1 (CLIC1), upregulated in several cancers (<xref ref-type="bibr" rid="B64">Peretti et&#x20;al., 2015</xref>).</p>
<p>Our recently published data, obtained by differential analysis between melanoma cells MDA-MB-435S and MDA-MB-435S-derived cell clones with decreased expression of integrin &#x3b1;V, identified key components of integrin &#x3b1;V&#x3b2;5 adhesion complexes, namely talin 1 and 2 (TLN1 and 2), &#x3b1;-actinin 1 and 4 (ACTN1 and 4), filamin A and B (FLNA and B), PLEC and vinculin (VCL) (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>), which are all part of the consensus adhesome (<xref ref-type="bibr" rid="B37">Horton et&#x20;al., 2015</xref>). All these proteins, except TLN2, were detected in Cal27 IACs, whereas VCL was detected in only two out of five samples. These data indicate that Cal27 cells in long term culture do form FAs, despite the fact that the relevant integrin subunits were not detected by MS (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). Therefore, these data suggest that &#x3b1;V integrin heterodimers are likely to be a low abundant component of the Cal27 adhesome under the conditions tested.</p>
<p>Type I HDs, found in stratified and pseudostratified epithelia, consist of integrin &#x3b1;6&#x3b2;4, PLEC, CD151, BP230 and BP180 (<xref ref-type="bibr" rid="B62">Owaribe et&#x20;al., 1990</xref>). Type II HDs, found in simple epithelia, consist only of integrin &#x3b1;6&#x3b2;4 and PLEC (<xref ref-type="bibr" rid="B80">Uematsu et&#x20;al., 1994</xref>; <xref ref-type="bibr" rid="B26">Fontao et&#x20;al., 1999</xref>). Since the main integrin identified in IACs from Cal27 cells was &#x3b1;6&#x3b2;4, we searched the MS data for other HD components. Out of the known HD-specific proteins, we detected only PLEC suggesting that Cal27 cells form type II&#x20;HDs.</p>
<p>Type II HDs are characterized by electron-dense regions connected to cytokeratin filaments (<xref ref-type="bibr" rid="B25">Fontao et&#x20;al., 1997</xref>). It is well known that intermediate filaments assembled from basal cell keratins KRT-5 and KRT-14 associate with the inner plaque of HDs via PLEC and BP230 (<xref ref-type="bibr" rid="B81">Walko et&#x20;al., 2015</xref>). Interestingly, both KRT-5 and KRT-14 and a plethora of additional keratins, i.e.,&#x20;KRT-1/2/4/6A/6B/8/9/10/13/15/16/17/18 were identified in Cal27 IACs. Since keratins can originate from MS sample preparation contamination (<xref ref-type="bibr" rid="B36">Hodge et&#x20;al., 2013</xref>) and provide false positives, we evaluated their significance by comparing the number of spectra for these keratins in Cal27 isolates with the adhesome of human breast carcinoma MDA-MB-231 cells which were simultaneously analyzed (unpublished data, data not shown). The most important difference was in the number of spectra for KRT-5 and KRT-14, which were represented with the highest number of spectra of all keratins and had a 10-fold higher number of spectra in Cal27 cells as compared to MDA-MB-231 cells (unpublished data, data not shown). In addition, a striking difference was observed in KRT-15/16/17 which were absent in IACs from MDA-MB-231 cells but present in Cal27 cells (<xref ref-type="sec" rid="s10">Supplementary Table S2.1</xref>). Indeed, it has been demonstrated that the expression of KRT-17 is higher in oral squamous cell carcinoma tissues compared to non-tumor tissues (<xref ref-type="bibr" rid="B16">Coelho et&#x20;al., 2015</xref>) but is also expressed in breast carcinoma (<xref ref-type="bibr" rid="B79">Turashvili et&#x20;al., 2007</xref>). Conversely, KRT-19 was not detected in the Cal27 adhesome unlike the MDA-MB-231 adhesome (<xref ref-type="sec" rid="s10">Supplementary Table S2.1</xref>). Together, these data indicate that enrichment in KRT-5 and KRT-14 is a feature of Cal27 cells, which further supports the formation of HDs by integrin &#x3b1;6&#x3b2;4. However, these data do not allow us to conclude whether KRT-5 and KRT-14 are an integral part of HDs. Therefore, based on the adhesome data we hypothesize that Cal27 cells in cell culture adhere preferentially through formation of type II&#x20;HDs.</p>
<p>A constructed PPI network (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>) further shows a group of desmosomal proteins, i.e.,&#x20;periplakin (PPL), desmogleins 2 and 3 (DSG2/3), plakophilins 1, 2 and 3 (PKP1/2/3), junction plakoglobin (PLAK) and desmoplakin (DSP). These proteins are not frequently detected in adhesome analysis and were absent in the MDA-MB-435S adhesome analyzed in the same manner (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>). However, melanoma cells MDA-MB-435S are metastatic and express mesenchymal markers, such as vimentin (<xref ref-type="bibr" rid="B30">Han et&#x20;al., 2014</xref>), unlike Cal27 cells which possess an epithelial phenotype (<xref ref-type="bibr" rid="B89">Yadav et&#x20;al., 2011</xref>). DSGs and PLAK, but also integrins &#x3b1;6 and &#x3b2;4, were detected in two types of human oral squamous carcinoma cell lines by MS in deroofed cells attached to glass coverslips (<xref ref-type="bibr" rid="B78">Todorovi&#x107; et&#x20;al., 2010</xref>).</p>
<p>MS analysis identified heat shock proteins and many ribosomal proteins (ribosomal protein large (RPL) and small (RPS)) and those related to RNA and protein synthesis such as DEAD box proteins (DDX). A plausible explanation is that adapter proteins, which interact with integrin mRNAs, could support specific integrin dimer formation (<xref ref-type="bibr" rid="B32">Hatzfeld and Magin, 2019</xref>). Actually, ribosomes have been found to co-localize with &#x3b2;3&#x20;integrin-enriched FAs on engagement with ECM proteins (<xref ref-type="bibr" rid="B86">Willett et&#x20;al., 2010</xref>). Similarly, the &#x3b1;6 integrin 3&#x2032;UTR is essential not only for the formation and localization of the &#x3b1;6&#x3b2;4 heterodimer to cell-matrix adhesions but also its stability (<xref ref-type="bibr" rid="B88">Woychek et&#x20;al., 2019</xref>). Finally, the Cal27 PPI network contains a group of nuclear proteins (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>).</p>
<p>In conclusion, our results indicate that Cal27 cells use preferentially, but not exclusively, integrin &#x3b1;6&#x3b2;4 for adhesion in cell culture, unlike melanoma MDA-MB-435S (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>), osteosarcoma U2OS, lung carcinoma A549 and melanoma A375 (<xref ref-type="bibr" rid="B53">Lock et&#x20;al., 2018</xref>) which all use integrin &#x3b1;V&#x3b2;5. The composition of the Cal27 adhesome and the absence of BP180 and BP230 indicate that these cells form type II HDs composed of &#x3b1;6&#x3b2;4 and PLEC, but these data do not allow us to conclude whether KRT-5 and KRT-14, which represent the majority of keratins in this cell line, are linked to these&#x20;HDs.</p>
</sec>
<sec id="s3-2">
<title>Comparison of Cal27 and 2B1 Adhesomes Suggests That <italic>De Novo</italic> Expression of Integrin &#x3b1;V&#x3b2;3 Increased the Abundance of FAs and Type II HDs</title>
<p>Since our previous data showed <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 in Cal27 cells induced differences in sensitivity to anticancer drugs (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>), we aimed to identify IAC proteins that contributed to the observed phenotype changes (<xref ref-type="sec" rid="s10">Supplementary Table S2.3</xref>). MS identified differences in IAC composition between Cal27 and 2B1 cells (<xref ref-type="fig" rid="F2">Figures 2A, B</xref>). Since 2B1 cells have increased expression of both &#x3b1;V&#x3b2;3 and &#x3b1;V&#x3b2;5, and demonstrated increased adhesion to both FN and VN (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>), we expected to detect more FA proteins in 2B1 compared to Cal27 cells. Indeed, we observed higher levels of proteins implicated in FA formation, i.e.,&#x20;FLNB, tensin-3 (TENS3) and myosin 10 (MYH10) in the 2B1 adhesome. FLNB and TENS3 were both found to be part of the integrin &#x3b1;V&#x3b2;5 adhesome (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>). FLNB is an actin-binding protein whose expression has been associated with invasiveness in osteosarcoma and radioresistant lung cancer cells (<xref ref-type="bibr" rid="B43">Iguchi et&#x20;al., 2015</xref>), in line with higher expressing and more invasive 2B1 cells. Tensins are regulators of Rho GTPase signaling and cell adhesion (<xref ref-type="bibr" rid="B7">Blangy, 2017</xref>). An unbiased assessment of IAC proteins with higher abundance in 2B1 compared to Cal27 cells using DAVID GO analysis suggested that they are mostly components of the ECM and FAs. Conversely, proteins present in lower levels in clones 2B1 compared to Cal27 cells were classified as intermediate filaments, ECM and cell-cell adherent junctions (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref> and <xref ref-type="sec" rid="s10">Supplementary Table&#x20;2.3</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Analysis and validation of IACs isolated from Cal27 cells and clone 2B1. <bold>(A)</bold> Volcano plot analysis of proteins detected in IACs isolated from Cal27 cells versus clone 2B1. IAC proteins from Cal27 and 2B1 cells are visualized as volcano plot after the analysis with QSpec/QProt to generate -Log (FDR) and fold change values. Cut off values of &#x2212;Log (FDR) &#x2265; 1 (red horizontal dotted line) corresponding to FDR &#x2264; 0.05 and &#x2212;Log (FDR) &#x2265; 1,3 (black horizontal dotted line) corresponding to FDR &#x2264; 0.1; and fold change &#x2265; 1.5 (black vertical dotted line) or 2 (red vertical dotted line) were used. Each dot on the plot represents 1 protein. Proteins with significantly different abundance between IACs of Cal27 and 2B1 cells, and of interest for this paper are marked with their gene name. Upper left quadrant&#x2013;proteins detected with lower levels of spectra in 2B1, upper right quadrant&#x2013;proteins detected with higher levels of spectra in 2B1, compared to Cal27. For this analysis, only proteins identified with a minimal number of spectral counts &#x2265; 4 in at least three out of five biological replicates in either of Cal27 or 2B1 set were used, FDR &#x3c; 5%, probability for protein identification &#x2265; 99.9% were visualized. <bold>(B)</bold> DAVID GO analysis of proteins from <bold>(A)</bold> with FDR &#x2264; 0.1 and fold change &#x2265; or &#x2264; 1.5, detected with higher (green) and lower (red) abundances in 2B1 as compared to Cal27. Statistically significant GO terms were presented in reverse <italic>x</italic>-axis of <italic>p</italic>-value from lowest (top) to the highest significance (bottom). Green represents GO terms annotated to the proteins whose abundance is higher in 2B1 than Cal27, and red to reverse. The <italic>p</italic>-value represents Benjamini corrected <italic>p</italic>-value. <bold>(C)</bold> WB analysis of IAC proteins from Cal27 and 2B1 cells. Seventy-two hours after seeding, IACs were isolated and WB analysis was performed. The results presented are representative of two independent experiments yielding similar results. PLEC, plectin; COL7A1, collagen VII; TLN1, talin 1; ITGB4, integrin subunit &#x3b2;4; LAMB3, laminin subunit &#x3b2;3; ITGB5, integrin subunit &#x3b2;5; KRT-14, keratin&#x20;14.</p>
</caption>
<graphic xlink:href="fcell-09-786758-g002.tif"/>
</fig>
<p>Other proteins detected at higher levels in IACs from 2B1 compared to Cal27 were the ECM proteins TNC, thrombospondin-1 (THBS1), TGFBI and EGF-like repeat, discoidin I-like domain-containing protein 3 (EDIL-3), high-temperature requirement serine protease (HTRA1) and heparan sulphate proteoglycan 2 (HSPG2, perlecan). Although the spectral counts for THBS1, EDIL-3, HTRA1 and HSPG2 in Cal27 cells were below the selected cut off value (<xref ref-type="sec" rid="s10">Supplementary Table S2.3</xref>), they showed increased abundance in 2B1 cells. TNC is an ECM protein which binds to many different integrin heterodimers, especially &#x3b1;V&#x3b2;3, but not &#x3b1;V&#x3b2;5 (<xref ref-type="bibr" rid="B58">Midwood et&#x20;al., 2016</xref>) and THBS1 is an extracellular mediator of matrix mechanotransduction that acts via integrin &#x3b1;V&#x3b2;1 to establish FAs (<xref ref-type="bibr" rid="B90">Yamashiro et&#x20;al., 2020</xref>). Therefore, their increased abundance in 2B1 IACs very likely reflects the <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3-containing FAs in 2B1 cells and/or increased expression of integrin &#x3b1;V&#x3b2;5 (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). THBS1 is also closely associated with transforming growth factor &#x3b2; (TGF-&#x3b2;). Latent TGF-&#x3b2; can be activated through different mechanisms, including integrins in concert with mechanical forces due to ECM stiffness and/or cytoskeletal forces, or by binding to the secreted and ECM protein THBS1 (<xref ref-type="bibr" rid="B5">Atanasova et&#x20;al., 2019</xref>). TGFBI, an ECM interacting protein, activates the FAK signaling pathway through its binding to integrin &#x3b1;V&#x3b2;5, enhances glycolysis and promotes pancreatic cancer cell migration (<xref ref-type="bibr" rid="B18">Costanza et&#x20;al., 2019</xref>) which is in line with our data of increased migration of 2B1 cells. The observed higher levels of actin are also in line with migration data (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). Higher level of EDIL3 in 2B1 cells is consistent with the increased amount of integrin &#x3b1;V&#x3b2;3 FAs (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). EDIL-3 (DEL-1) is a ECM protein that promotes adhesion of endothelial cells through interaction with the &#x3b1;V&#x3b2;3 (<xref ref-type="bibr" rid="B35">Hidai et&#x20;al., 1998</xref>; <xref ref-type="bibr" rid="B91">Yuh et&#x20;al., 2020</xref>). The connection between integrin &#x3b1;V&#x3b2;3 and EDIL3 has been shown in HNSCC samples compared with non-cancerous controls. Namely, <xref ref-type="bibr" rid="B12">Cen et&#x20;al. (2018)</xref> demonstrated decreased expression of MiR-375-3p, thus acting as a tumor suppressor via regulating tumor-related genes LAMC1, EDIL3, FN1, VEGFA, IGF2BP2, and IGF2BP3 in HNSCC, which were greatly enriched in the pathways of integrin &#x3b2;3 cell surface interactions. Moreover, EDIL3 is significantly correlated with mesenchymal phenotype, angiogenesis, and tumor progression in lung adenocarcinoma (<xref ref-type="bibr" rid="B44">Jeong et&#x20;al., 2017</xref>). It also promotes epithelial&#x2013;mesenchymal transition (EMT) and paclitaxel resistance through interaction with integrin &#x3b1;V&#x3b2;3 in cancer cells and its blockade by cilengitide restores sensitivity and reverts EMT (<xref ref-type="bibr" rid="B27">Gasca et&#x20;al., 2020</xref>). HTRA1, a serine protease shows higher levels in 2B1 IACs compared to Cal27. It has a variety of targets, including ECM proteins such as FN (<xref ref-type="bibr" rid="B45">Jiang et&#x20;al., 2012</xref>). Higher levels of HSPG2 (perlecan) in 2B1 is consistent with data showing that intercellular deposition of HSPG2, a basement-membrane type heparan sulphate proteoglycan which can interact with &#x3b2;1 and &#x3b2;3 integrins (<xref ref-type="bibr" rid="B33">Hayashi et&#x20;al., 1992</xref>), is enhanced in oral epithelial dysplasia and carcinoma <italic>in situ</italic> (<xref ref-type="bibr" rid="B31">Hasegawa et&#x20;al., 2016</xref>). In conclusion, many proteins detected at higher levels in IACs from 2B1 compared to Cal27 are related to increased amount of integrins, either &#x3b1;V&#x3b2;3 and/or &#x3b1;V&#x3b2;5, detected previously (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>).</p>
<p>As we emphasized previously, the main integrin used by Cal27 cells in long term culture is integrin &#x3b1;6&#x3b2;4. Interestingly, we found increased levels of both integrin subunits &#x3b1;6 and &#x3b2;4 in IACs of 2B1 cells, compared to Cal27, although this difference wasn&#x2019;t statistically significant. We wondered whether laminin-332, the main laminin used by integrin &#x3b1;6&#x3b2;4 for adhesion (<xref ref-type="bibr" rid="B81">Walko et&#x20;al., 2015</xref>), was also present in higher amounts in 2B1 cells. The IAC MS data showed higher levels of all three laminin subunits LAMA3, LAMB3 and LAMC2 (only LAMA3 difference wasn&#x2019;t statistically significant) in IACs from 2B1 cells compared to Cal27 (<xref ref-type="sec" rid="s10">Supplementary Table S2.3</xref>), indicating that 2B1 cells secrete an increased abundance of laminin-332. Interestingly, higher levels of the &#x3b1;6&#x3b2;4 interacting ECM protein laminin subunit &#x3b1;5 (LAMA5) were also detected in 2B1. LAMA5 is a part of laminin-511 (&#x3b1;5&#x3b2;1&#x3b3;1), a potent adhesive and pro-migratory ECM substrate for a variety of normal and tumor cell lines <italic>in&#x20;vitro</italic> (<xref ref-type="bibr" rid="B66">Pouliot and Kusuma, 2013</xref>). In Cal27 neither laminin &#x3b2;1 nor &#x3b3;1 specific spectra were observed, while in 2B1 none or very low number of spectra in different samples for laminin &#x3b2;1 or &#x3b3;1 were detected, thus preventing us to conclude on the actual difference in laminin-511 expression between the two cell lines (<xref ref-type="sec" rid="s10">Supplementary Table&#x20;S2.3</xref>).</p>
<p>Many proteins were found to be present in lower amounts in IACs from 2B1 compared to Cal27 (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>; <xref ref-type="sec" rid="s10">Supplementary Table S2.3</xref>) including many keratins, i.e.,&#x20;KRT-5, -6A, -6B, -13, -14, -15, -16 and -17. KRT-5 and KRT-14 are the main keratins employed by Cal27 cells. This finding was surprising, as 2B1 cells showed an increased amount of integrin &#x3b1;6 and &#x3b2;4 subunits. This indicated that they are not part of type II HDs. <xref ref-type="bibr" rid="B77">Te Molder et&#x20;al. (2019)</xref> described hybrid cell-matrix adhesions which are present in the central region of the cells containing CD151 - &#x3b1;3&#x3b2;1/&#x3b1;6&#x3b2;4 integrin complexes and PLEC, which were not anchored to the keratin filaments. In addition, CD151 was necessary for proper organization of these integrins in the central region of the cells. However, we did not observe CD151 nor integrin &#x3b1;3 in the adhesome of Cal27 or 2B1&#x20;cells.</p>
<p>Other proteins found at lower levels in IACs from 2B1 cells were PPL and DSP. PPL is a member of plakin family of proteins implicated in crosstalk between three major cytoskeletal networks. PPL, together with DSP, envoplakin, and epiplakin is predominantly involved in intermediate filament binding as components of desmosomes and the cornified envelope (<xref ref-type="bibr" rid="B67">Quick, 2018</xref>). Since PPL is mostly downregulated in cancer, e.g., in esophageal squamous cell carcinoma (<xref ref-type="bibr" rid="B61">Nishimori et&#x20;al., 2006</xref>) and many other cancers regulating cancer cell growth, survival, migration, invasion and drug resistance (<xref ref-type="bibr" rid="B85">Wesley et&#x20;al., 2021</xref>), its downregulation in more therapy resistant and more migratory 2B1 cells (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>) was expected. In Cal27 cells we detected almost all components of desmosomes, i.e.,&#x20;DSG 2/3, PKP 1/2/3, PLAK and DSP. We also detected KRT-5 and KRT-14 filaments which were shown to support stable desmosomes (<xref ref-type="bibr" rid="B54">Loschke et&#x20;al., 2016</xref>). Both plakophilins (PKP1/2), DSP, KRT-5 and KRT-14 were less abundant in 2B1 cells while DSG 2/3 were detected with low number of spectra preventing us to conclude on its differential expression. These data indicate that both cell lines form desmosomes which are less abundant in 2B1 compared to Cal27 cells, and indicate that KRT-5 and KRT-14 filaments are very likely anchored with desmosomes. The observed reduced cell-cell contact in 2B1 compared to Cal27 cells is in line with increased migration of 2B1 compared to Cal27 (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). It remains to be determined how desmosome components are retained through the IAC isolation protocol.</p>
<p>Additional proteins found in lower amount in 2B1 cells compared to Cal27 were two nuclear proteins, nuclear mitotic apparatus protein 1 (NUMA1) and nucleoporin 153 (NUP153). Finally, neuroblast differentiation-associated protein AHNAK is also present in reduced amount in 2B1 IACs. AHNAK was found in several adhesomes (<xref ref-type="bibr" rid="B48">Kuo et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B37">Horton et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>), in RAs (<xref ref-type="bibr" rid="B53">Lock et&#x20;al., 2018</xref>) and as &#x3b2;4 interacting protein (<xref ref-type="bibr" rid="B59">Myllym&#xe4;ki et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B83">Wang et&#x20;al., 2020</xref>) and was shown to function as a tumor suppressor via modulation of TGF&#x3b2;/Smad signaling pathway (<xref ref-type="bibr" rid="B50">Lee et&#x20;al., 2014</xref>). However, its involvement in tumor progression is still unknown.</p>
</sec>
<sec id="s3-3">
<title>Validation of IAC Proteins Differentially Detected in Cal27 and 2B1 Adhesomes</title>
<p>The increased abundance of &#x3b2;4 in IACs of 2B1 cells was confirmed using WB of isolated IACs (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>), while increased expression of integrin subunit &#x3b1;6 in 2B1 was confirmed by flow cytometry (<xref ref-type="sec" rid="s10">Supplementary Figure S2A</xref>). The formation of HDs can be initiated through laminin-332 deposited by the cells (<xref ref-type="bibr" rid="B51">Litjens et&#x20;al., 2006</xref>). Therefore, the increased level of HDs is in line with increased deposition of corresponding ECM proteins, i.e.,&#x20;laminin-332 whose increased expression in 2B1 was confirmed by WB of LAMB3 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>) supporting the MS analysis of all laminin-332 components in IAC isolates. We have also found COL7A1 expression in IAC isolates of both Cal27 and 2B1 cells and the expression was increased in 2B1 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). Type VII collagen (COL7A1) is a major component of anchoring fibrils, providing mechanical strength via linking the basal lamina and the underlying connective tissue, and is synthesized by keratinocytes and fibroblasts (<xref ref-type="bibr" rid="B29">Goletz et&#x20;al., 2017</xref>). The cytoskeletal linker PLEC, part of HDs type I and II, was shown to mediate crosstalk between HDs which oppose force transduction and traction force generation by FAs by coupling intermediate filaments to the actin cytoskeleton (<xref ref-type="bibr" rid="B94">Zuidema et&#x20;al., 2020</xref>). In accordance, WB analysis of IAC isolates demonstrated increased levels of PLEC in 2B1 cells compared to Cal27 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>) in contrast to the MS analysis which indicated similar amounts (<xref ref-type="sec" rid="s10">Supplementary Table S2.3</xref>). Although the classical type I HD component BP180 was not detected by MS, we did observe similar BP180 expression in both cell lines by WB and the BP180 was weak, if at all present, in isolated Cal27 and 2B1 IACs (data not shown). These results support the conclusion that both cell types form type II HDs. Finally, we confirmed decreased levels of KRT-14 in 2B1 cells compared to Cal27 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>), thus supporting the conclusion that HDs in Cal27 and 2B1 cells have reduced anchorage to KRT-5 and KRT-14. Interestingly, WB analysis of KRT-14 in Cal27 and 2B1 cells upon integrin &#x3b2;4 knockdown showed that the expression of KRT-14 does not change in Cal27 or 2B1 cells upon integrin &#x3b2;4 knockdown (<xref ref-type="sec" rid="s10">Supplementary Figure&#x20;S2B</xref>).</p>
<p>Integrin subunit &#x3b2;5 was not detected by MS in Cal27, but in 2B1 cells there was a low detection in 1 repeat, while integrin subunits &#x3b1;V and &#x3b2;3 were not detected at all. However, the expression of integrin heterodimer &#x3b1;V&#x3b2;5 in Cal27 and its increased expression in 2B1 cells, as well as the <italic>de novo</italic> expression of &#x3b1;V&#x3b2;3 in 2B1 cells was demonstrated previously (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). In addition, the difference in &#x3b1;V&#x3b2;5 integrin abundance in Cal27 and 2B1 IAC isolates was confirmed using WB (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>). Although TLN1 was found at low levels by MS in IACs, WB analysis demonstrated increased levels of TLN1 in 2B1 cells compared to Cal27, demonstrating further increased amount of FAs in 2B1 compared to Cal27 (<xref ref-type="fig" rid="F2">Figure&#x20;2C</xref>).</p>
<p>Analysis of the Cal27 and 2B1 adhesome upon long-term culture detected only &#x3b1;6 and &#x3b2;4 integrin subunits, indicating that these cells preferentially, but not exclusively, use integrin &#x3b1;6&#x3b2;4 for adhesion. We have recently published results of adhesome analysis of human melanoma cell line MDA-MB-435S in which we found predominantly integrin subunits &#x3b1;V and &#x3b2;5 (<xref ref-type="bibr" rid="B63">Parad&#x17e;ik et&#x20;al., 2020</xref>), that is in accordance with our unpublished results for human melanoma cell line RPMI-7951 and breast carcinoma cell line MDA-MB-231, as well as with results published by <xref ref-type="bibr" rid="B53">Lock et&#x20;al. (2018)</xref> in human osteosarcoma U2OS, lung carcinoma A549 and melanoma A375 cells. Unlike Cal27, all these cell lines are highly metastatic cells with more mesenchymal than epithelial characteristics (<xref ref-type="bibr" rid="B89">Yadav et&#x20;al., 2011</xref>). We have shown that 2B1 cells express increased amount of integrin &#x3b1;6&#x3b2;4 on the cell surface. Integrin &#x3b1;6&#x3b2;4 has been shown to form HDs (<xref ref-type="bibr" rid="B81">Walko et&#x20;al., 2015</xref>) and therefore we searched for more HD components and found only PLEC which was more abundant in 2B1 compared to Cal27 cells only in further validation experiments using WB. The differential expression of &#x3b1;6&#x3b2;4 also has an effect on ECM protein characteristics for HDs, i.e.,&#x20;in 2B1 cells we found increased laminin-332 as well as COL7A1, confirming existence of HDs in both cell lines. Interestingly, we also observed increased amount of another BM component, perlecan which is also more abundant in 2B1 compared to Cal27. An important gene expression signature highly expressed in a subset of recurrent HNSCC includes laminin &#x3b1;3, &#x3b2;3 and &#x3b3;2, components of the laminin-332, as well as integrins &#x3b1;6 and &#x3b2;4 forming integrin &#x3b1;6&#x3b2;4, which serves as its ligand, suggesting a potentially aggressive phenotype prone to invasion and metastasis (<xref ref-type="bibr" rid="B28">Ginos et&#x20;al., 2004</xref>). HNSCC tumor biology is strongly associated with deregulations within the ECM compartment. Laminin-332 is one of the main isoforms associated with malignant transformation, contributing to proliferation, adhesion, migration, invasion, and metastasis (<xref ref-type="bibr" rid="B69">Ramovs et&#x20;al., 2017</xref>), due to its involvement in the regulation of several pathways, including the activation of the EGFR/MAPK as well as PI3K/AKT. Therefore, laminin-332 may represent an attractive potential therapeutic target for these tumors (<xref ref-type="bibr" rid="B57">Meireles Da Costa et&#x20;al., 2021</xref>).</p>
<p>
<xref ref-type="bibr" rid="B78">Todorovi&#x107; et&#x20;al. (2010)</xref> used a method for IAC enrichment (deroofing the cells with ammonium hydroxide and the removal of cytosolic and organellar proteins by stringent water wash) and&#x20;MS analysis of proteins associated with the basal surface of the cell and its underlying ECM. They analysed differential expression in PLAK-null cells compared to PLAK heterozygous mouse keratinocytes and observed strong downregulation of FN, TNC, integrins &#x3b1;6 and &#x3b2;4 and hemidesmosome component BP180. They applied the same method to compare human oral squamous carcinoma lines CAL33 and UM-SCC-1 which originate from tongue and the roof of the mouth, respectively, and again found differential expression of cell-cell adhesion proteins DSG2 and PLAK and integrin &#x3b1;4, thus supporting the important role of desmosomes and HDs in HNSCC. These results indicate regulation of HDs by&#x20;desmosomes. However, little is known about the regulation of desmosome adhesion by cell-ECM interaction, FAs and HDs. Latest data clearly showed that HDs and FAs affect each other&#x2019;s distribution. In normal human epithelial keratinocytes they are identified as separate but linked entities which cooperate to coordinate the dynamic interplay between the keratin and actin cytoskeleton (<xref ref-type="bibr" rid="B65">Pora et&#x20;al., 2019</xref>). FAs and HDs share only one component, namely PLEC, while HDs and desmosomes share keratins. Our data indicate that there is crosstalk between FAs, HDs and desmosomes. A better understanding of FAs, HDs and desmosomes will provide novel clues into the molecular mechanisms that regulate adhesion, migration and survival in cancer cells. These studies may reveal new strategies&#x20;for cancer treatment. In conclusion, our data indicate that <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 in Cal27 results in upregulation of &#x3b1;V&#x3b2;5, either of them contributing to the upregulation of HDs leading to an altered ventral membrane environment with different links from integrins and the ECM to IAC components and the cytoskeleton. MS data suggest that it is possible that a reduced amount of desmosomes has occurred but this should be verified by other methods and is outside the scope of the research presented in this&#x20;paper.</p>
</sec>
<sec id="s3-4">
<title>Cal27 and 2B1 Cells Form Type II HD-Like Structures</title>
<p>Our MS analysis of the Cal27 cell adhesome identified only type II HD components, &#x3b1;6&#x3b2;4 integrin and PLEC (<xref ref-type="sec" rid="s10">Supplementary Table&#x20;2.1</xref>). Differential analysis showed increased levels of integrins &#x3b1;6, &#x3b2;4 and PLEC, and decreased levels of KRT-5 and KRT-14 in IACs from 2B1 cells, suggesting a reduced link of type II HDs adhesions with keratins. To analyze the cellular localization of integrin heterodimer &#x3b1;6&#x3b2;4 we performed IF analysis using antibodies directed against integrins &#x3b1;6 and &#x3b2;4 and demonstrated typical integrin &#x3b1;6 and &#x3b2;4 staining, i.e.,&#x20;diffuse ventral membrane localization in cauliflower or leopard skin pattern (<xref ref-type="fig" rid="F3">Figure&#x20;3</xref>). We also performed IF analysis using antibodies against KRT-14 (<xref ref-type="sec" rid="s10">Supplementary Figure S3</xref>). Surprisingly, we observed a different KRT-14 pattern between the cell types. In Cal27 cells KRT-14 was distributed at cell edges, whilst in 2B1 cells KRT-14 was more diffuse, and the KRT-14 network was dispersed throughout the cytoplasm, which was particularly visible when moving away from the bottom of the cell into the cell&#x20;body.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Integrin subunits &#x3b1;6 and &#x3b2;4&#x20;co-localize in both Cal27 or 2B1 cells. Confocal z stack images of Cal27 and 2B1 cells. Forty-eight hours after seeding on coverslips, cells were fixed, permeabilized, incubated with antibodies against integrin anti-&#x3b2;4 (ITGB4) antibody followed by Alexa-Fluor 488-conjugated antibody (green) and integrin anti-&#x3b1;6 (ITGA6) antibody followed by Alexa-Fluor 555-conjugated antibody (red). Nuclei were stained with DAPI (blue). Analysis was performed using TCS SP8 Leica. Scale bar &#x3d; 10&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fcell-09-786758-g003.tif"/>
</fig>
<p>Due to the limited resolution of IF microscopy, we analyzed HDs in Cal27 and 2B1 cells by transmission electron microscopy (TEM). In TEM, HDs appear as tripartite structures consisting of an inner and outer plaque and a sub-basal dense plate. The inner hemidesmosomal plaque is composed of the PLEC and BP230 proteins, which are involved in connecting the HD to the keratin intermediate filament system. The outer plaque contains the hemidesmosomal transmembrane proteins &#x3b1;6&#x3b2;4 and BP180. The integrin &#x3b1;6&#x3b2;4, a receptor for laminin-332 in the epidermal basement membrane, binds to the intermediate filament anchoring protein PLEC (<xref ref-type="bibr" rid="B8">Borradori and Sonnenberg, 1999</xref>; <xref ref-type="bibr" rid="B81">Walko et&#x20;al., 2015</xref>). Cal27 and 2B1 cells were cultured for 7&#x20;days on Aclar to allow transverse sections to be viewed by TEM (<xref ref-type="fig" rid="F4">Figure&#x20;4</xref>). Both Cal27 and 2B1 cells formed cell layers of 1&#x2013;2 cell depth. Polarization of cells was apparent, with flattened ventral membrane surfaces next to a small layer of secreted ECM and microvilli on the dorsal membrane (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). We observed many areas with increased plasma membrane density that were in close proximity to the secreted ECM (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). In addition, many areas displayed increased plasma membrane density alone. Therefore, in agreement with the MS data, the TEM analysis identified plasma membrane adhesion structures that did not display the fully mature HD stratification observed for type I HDs that contain all HD components (<xref ref-type="bibr" rid="B80">Uematsu et&#x20;al., 1994</xref>; <xref ref-type="bibr" rid="B26">Fontao et&#x20;al., 1999</xref>), and supports the conclusion that Cal27 and 2B1 cells form type II HDs. Of interest, the TEM analysis also revealed the presence of cell-cell junctions such as desmosomes (<xref ref-type="fig" rid="F4">Figure&#x20;4C</xref>), that is in line with MS data containing many desmosomal proteins (<xref ref-type="sec" rid="s10">Supplementary Table&#x20;S2.3</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Cal27 and 2B1 cells form HD-like structures which are indicative as type II HDs. <bold>(A&#x2013;C)</bold> Cal27 and 2B1 cells were cultured on Aclar for up to 7&#x20;days and transverse sections of the cell-ECM interface were prepared, imaged by TEM, and a range of magnifications shown. <bold>(A)</bold> Lower magnification images of cell monolayers that have formed a flattened basal surface with a thin layer of ECM ($) proximal to the area where the Aclar film (@) would have occupied. <bold>(B)</bold> Higher magnification images of the cell-ECM interface. Arrowheads (<sup>&#x25b2;</sup>) indicate the approximate position of some type II HDs (indicated from the extracellular side) which are located at the plasma membrane (&#x2a;) and link to cytoplasmic cytokeratin filaments (&#x23;). <bold>(C)</bold> Areas of cells to illustrate the formation of desmosomes. All images are orientated with the cell-ECM interface towards the top of the images. Other symbols used are [N &#x3d; nucleus; Open arrow &#x3d; luminal side with microvilli; Filled arrow &#x3d; basal surface next to ECM and aclar.; &#x2020; &#x3d; cell-cell junction where you can sometimes see electron dense desmosomes (<sup>&#x25b2;&#x25b2;</sup>) as shown in <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fcell-09-786758-g004.tif"/>
</fig>
</sec>
<sec id="s3-5">
<title>Knockdown of Integrin &#x3b2;4 Confers Resistance to CDDP, MMC and DOX in Both Cal27 and 2B1 Cells</title>
<p>The <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 in Cal27 cells confers resistance to cDDP, MMC and DOX (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). Since we found increased expression of integrin &#x3b1;6&#x3b2;4 in 2B1 compared to Cal27 cells we aimed to investigate the possible involvement of &#x3b1;6&#x3b2;4 integrin in sensitivity to these anticancer drugs. We transfected Cal27 and 2B1 cells with siRNA specific for integrin &#x3b2;4 and measured sensitivity to anticancer drugs as compared to the cells transfected with control siRNA. WB confirmed the decreased expression of integrin &#x3b2;4 (<xref ref-type="sec" rid="s10">Supplementary Figure S2B</xref>). Of interest, this analysis also revealed that integrin &#x3b2;4 expression was increased in 2B1 total cell lysate compared to Cal27. To test whether integrin &#x3b2;4 knockdown decreased the amount of integrin &#x3b1;6&#x3b2;4 heterodimer at the cell surface we measured the expression of integrin subunit &#x3b1;6 using flow cytometry. Indeed, integrin &#x3b2;4 knockdown decreased the amount of &#x3b1;6 integrin subunit on the cell surface (<xref ref-type="sec" rid="s10">Supplementary Figure S2A</xref>), thus confirming that integrin &#x3b2;4 knockdown decreases the expression of &#x3b1;6&#x3b2;4 heterodimer at the cell surface.</p>
<p>Both Cal27 and cell clone 2B1 transfected with control siRNA retained similar sensitivity to cDDP, MMC and DOX as nontransfected cells (data not shown). However, Cal27 and 2B1 cells transfected with &#x3b2;4-specific siRNA demonstrated resistance, i.e.,&#x20;decreased sensitivity to cDDP, MMC and DOX compared to cells transfected with control siRNA (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). In the absence of the anticancer drug, both Cal27 and 2B1 cells transfected with integrin &#x3b2;4-specific siRNA demonstrate decreased proliferation compared to control transfection. Upon exposure to different concentrations of cDDP, MMC or DOX, the resistance of 2B1 cells compared to Cal27, both transfected with control siRNA, was retained which corresponds to previously published data (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). However, in both cells transfected with integrin &#x3b2;4-specific siRNA we observed increased survival (resistance) compared to their own controls. This result confirms the involvement of integrin &#x3b1;6&#x3b2;4 in signaling pathways affecting sensitivity of both cell lines to anticancer drugs (<xref ref-type="fig" rid="F5">Figure&#x20;5</xref>). However, since we observed a similar effect of decreased expression of &#x3b1;6&#x3b2;4 in both Cal27 and 2B1 cells, we conclude that mechanisms of anticancer drug resistance triggered by <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3 and decreased expression of &#x3b1;6&#x3b2;4 are independent, i.e.,&#x20;have different mechanisms.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Cal27 and 2B1 cells demonstrate decreased sensitivity to CDDP, MMC or DOX upon knockdown of integrin &#x3b2;4 (si(&#x3b2;4)) as compared to control Cal27 and 2B1 cells transfected with control siRNA (si(-)). Twenty-four hours upon siRNA transfection, cells were seeded in 96-well plates and 24&#xa0;h later treated with different concentrations of CDDP, MMC or DOX. Cytotoxicity was measured by MTT assay 72&#xa0;h later. Average absorbance data&#x20;&#xb1; S.D. indicating survival, are representative of at least three independent experiments yielding similar results. Data were analyzed by two-way ANOVA with Bonferroni post-test. ns, not significant; &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01; &#x2a;&#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.001.</p>
</caption>
<graphic xlink:href="fcell-09-786758-g005.tif"/>
</fig>
<p>The expression of integrin &#x3b1;V&#x3b2;3 is significantly higher in tongue SCC cells than in epithelium cells in normal tissues (<xref ref-type="bibr" rid="B1">Ahmedah et&#x20;al., 2017</xref>). In our previous work we showed the integrin crosstalk event in tongue squamous carcinoma cells Cal27-derived drug resistant cell clone 2B1, obtained by <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3, i.e.,&#x20;increased amount of integrin &#x3b1;V&#x3b2;5 in 2B1 cells whose expression was unrelated to integrin &#x3b1;V&#x3b2;3-mediated anticancer drug resistance to cDDP,&#x20;MMC and DOX (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>). Therefore, our cell model imitates what might happen during progression&#x20;of HNSCC. Here, we assessed the adhesome of both cell lines in order to obtain further information on the components of the adhesion complexes and their possible role in regulation of the sensitivity to the anticancer drugs. In conclusion, our major finding is that both Cal27 and 2B1 cells preferentially, but not exclusively, use integrin &#x3b1;6&#x3b2;4 for adhesion forming type II HDs. Integrin &#x3b1;6&#x3b2;4 also provides a physiological role in sensitivity to three different anticancer&#x20;drugs.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>Since integrins have been implicated in sensitivity to chemotherapy they are therefore potential therapeutic targets, in addition to their already well-described roles as therapeutics in anti-clotting, multiple sclerosis and ulcerative colitis (<xref ref-type="bibr" rid="B20">Desgrosellier and Cheresh, 2010</xref>; <xref ref-type="bibr" rid="B72">Seguin et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B21">Dickreuter and Cordes, 2017</xref>; <xref ref-type="bibr" rid="B68">Raab-Westphal et&#x20;al., 2017</xref>). HDs are important in epithelial cell adhesion, and mutations in any of the six genes encoding the structural components of HDs cause the hereditary skin blistering disorder epidermolysis bullosa (<xref ref-type="bibr" rid="B56">McGrath, 2015</xref>). In addition to their adhesion function, HDs may also play an important role in signal transduction (<xref ref-type="bibr" rid="B83">Wang et&#x20;al., 2020</xref>). Finally, HDs play a role in HNSCC progression since its metastatic growth is correlated with upregulation and redistribution of HD components (<xref ref-type="bibr" rid="B34">Herold-Mende et&#x20;al., 2001</xref>). Our results indicate that type&#x20;II&#x20;HDs in both&#x20;Cal27 and 2B1 cells regulate sensitivity to cDDP, MMC and DOX independently of &#x3b1;V&#x3b2;3. These data&#x20;also reveal another&#x20;integrin crosstalk event in Cal27 tongue squamous cell carcinoma cells, i.e.,&#x20;integrin &#x3b1;V&#x3b2;3-induced upregulation of &#x3b1;6&#x3b2;4, in addition to the previously described integrin crosstalk event, i.e.,&#x20;upregulation of integrin&#x20;&#x3b1;V&#x3b2;5 upon <italic>de novo</italic> expression of &#x3b1;V&#x3b2;3 (<xref ref-type="bibr" rid="B74">Stojanovi&#x107; et&#x20;al., 2016</xref>).</p>
<p>Only those integrins assembled as heterodimers, a process which occurs in the endoplasmic reticulum, are displayed on the cell surface and able to bind their ligands and trigger signaling. Therefore, it is not possible to determine a cell specific integrin repertoire, that is used for cell adhesion and signaling, using transcription analysis (<xref ref-type="bibr" rid="B70">Samar&#x17e;ija et&#x20;al., 2020</xref>). With the development of protocols to permit the isolation and proteomic analysis of IACs it is possible to study the integrins used by particular cell type as well as IAC composition (adhesome) in detail (<xref ref-type="bibr" rid="B41">Humphries et&#x20;al., 2019</xref>). Our data comparing adhesomes of HNSCC cell line Cal27, and its clone 2B1 obtained by <italic>de novo</italic> expression of integrin &#x3b1;V&#x3b2;3, represent a valuable resource to improve our understanding of the involvement of integrins in sensitivity to chemotherapy as well as integrin crosstalk mechanisms.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are publicly available. This data can be found in the ProteomeXchange repository with the dataset identifier: PXD028810.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>AA-R and JH contributed to the study conception and design. AT, JH, IS, NS, JZ, K&#x10c;, MT, MP, DN, HK, and AA-R performed research by material preparation, data collection and analysis. The first draft of the manuscript was written by AA-R that was complemented by JH and MH. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by the Croatian Science Foundation Project (Grants IP-2019-04-1577 and IP-2013-11-2465 to AA-R), Cancer Research United&#x20;Kingdom (Grant C13329/A21671 to MH) and the EuroCellNet COST Action CA15214 (Short Term Scientific Mission (STSM) of&#x20;MP).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s9">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, orclaim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ack>
<p>We thank David Knight and Aleksandr Mironov of the Biological Mass Spectrometry (RRID: SCR_020987) and Electron Microscopy (RRID: SCR_021147) Core Facilities at The University of Manchester for assistance.</p>
</ack>
<sec id="s10">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2021.786758/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2021.786758/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table2.xlsx" id="SM1" mimetype="application/xlsx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
<supplementary-material xlink:href="DataSheet1.pdf" id="SM2" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmedah</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Patterson</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Shnyder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sheldrake</surname>
<given-names>H.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>RGD-Binding Integrins in Head and Neck Cancers</article-title>. <source>Cancers</source> <volume>9</volume> (<issue>6</issue>), <fpage>56</fpage>. <pub-id pub-id-type="doi">10.3390/cancers9060056</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Albiges-Rizo</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Destaing</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Fourcade</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Planus</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Block</surname>
<given-names>M. R.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Actin Machinery and Mechanosensitivity in Invadopodia, Podosomes and Focal Adhesions</article-title>. <source>J.&#x20;Cel Sci.</source> <volume>122</volume>, <fpage>3037</fpage>&#x2013;<lpage>3049</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.052704</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ambriovi&#x107;-Ristov</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gabrilovac</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>&#x10c;imbora-Zovko</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Osmak</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Increased Adenoviral Transduction Efficacy in Human Laryngeal Carcinoma Cells Resistant to Cisplatin Is Associated with Increased Expression of Integrin ?v?3 and coxsackie Adenovirus Receptor</article-title>. <source>Int. J.&#x20;Cancer</source> <volume>110</volume> (<issue>5</issue>), <fpage>660</fpage>&#x2013;<lpage>667</lpage>. <pub-id pub-id-type="doi">10.1002/ijc.20176</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Apweiler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bairoch</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>W. C.</given-names>
</name>
<name>
<surname>Boeckmann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Ferro</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>UniProt: The Universal Protein Knowledgebase</article-title>. <source>Nucleic Acids Res.</source> <volume>32</volume> (<issue>DATABASE ISS.</issue>), <fpage>D115</fpage>&#x2013;<lpage>D119</lpage>. <comment>Oxford Academic</comment>. <pub-id pub-id-type="doi">10.1093/nar/gky09210.1093/nar/gkh131</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Atanasova</surname>
<given-names>V. S.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Webster</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Agarwal</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Lim</surname>
<given-names>Y. Z.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Thrombospondin-1 Is a Major Activator of TGF-&#x3b2; Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>139</volume> (<issue>7</issue>), <fpage>1497</fpage>&#x2013;<lpage>1505</lpage>. <comment>Elsevier B.V.e5</comment>. <pub-id pub-id-type="doi">10.1016/j.jid.2019.01.011</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aumailley</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Brucknertuderman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Carter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Deutzmann</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Edgar</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ekblom</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>A Simplified Laminin Nomenclature</article-title>. <source>Matrix Biol.</source> <volume>24</volume> (<issue>5</issue>), <fpage>326</fpage>&#x2013;<lpage>332</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2005.05.006</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blangy</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Tensins Are Versatile Regulators of Rho GTPase Signalling and Cell Adhesion</article-title>. <source>Biol. Cel</source> <volume>109</volume> (<issue>3</issue>), <fpage>115</fpage>&#x2013;<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1111/boc.201600053</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Borradori</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Structure and Function of Hemidesmosomes: More Than Simple Adhesion Complexes</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>112</volume> (<issue>4</issue>), <fpage>411</fpage>&#x2013;<lpage>418</lpage>. <comment>Blackwell Publishing Inc</comment>. <pub-id pub-id-type="doi">10.1046/j.1523-1747.1999.00546.x</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boudhraa</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Bouchon</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Viallard</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>D&#x27;Incan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Degoul</surname>
<given-names>F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Annexin A1 Localization and its Relevance to Cancer</article-title>. <source>Clin. Sci.</source> <volume>130</volume> (<issue>4</issue>), <fpage>205</fpage>&#x2013;<lpage>220</lpage>. <comment>Portland Press Ltd</comment>. <pub-id pub-id-type="doi">10.1042/CS20150415</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brozovi&#x107;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Majhen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Roje</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mikac</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Jakopec</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2008</year>). <article-title>&#x3b1;v&#x3b2;3&#x20;Integrin-Mediated Drug Resistance in Human Laryngeal Carcinoma Cells Is Caused by Glutathione-Dependent Elimination of Drug-Induced Reactive&#x20;Oxidative Species</article-title>. <source>Mol. Pharmacol.</source> <volume>74</volume> (<issue>1</issue>), <fpage>298</fpage>&#x2013;<lpage>306</lpage>. <pub-id pub-id-type="doi">10.1124/mol.107.043836</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Byron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Askari</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Jacquemet</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Koper</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Warwood</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>A Proteomic Approach Reveals Integrin Activation State-Dependent Control of Microtubule Cortical Targeting</article-title>. <source>Nat. Commun.</source> <volume>6</volume>, <fpage>1</fpage>&#x2013;<lpage>14</lpage>. <comment>Nature Publishing Group</comment>. <pub-id pub-id-type="doi">10.1038/ncomms7135</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cen</surname>
<given-names>W-N.</given-names>
</name>
<name>
<surname>Pang</surname>
<given-names>J.-S.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Bao</surname>
<given-names>W.-G.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>R.-Q.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>The Expression and Biological Information Analysis of miR-375-3p in Head and Neck Squamous Cell Carcinoma Based on 1825 Samples from GEO, TCGA, and Peer-Reviewed Publications</article-title>. <source>Pathol. - Res. Pract.</source> <volume>214</volume> (<issue>11</issue>), <fpage>1835</fpage>&#x2013;<lpage>1847</lpage>. <pub-id pub-id-type="doi">10.1016/j.prp.2018.09.010</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chastney</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Lawless</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Warwood</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Topological Features of Integrin Adhesion Complexes Revealed by Multiplexed Proximity Biotinylation</article-title>. <source>J.&#x20;Cel. Biol. NLM (Medline)</source> <volume>219</volume> (<issue>8</issue>), <fpage>e202003038</fpage>. <pub-id pub-id-type="doi">10.1083/jcb.202003038</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Fermin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nesvizhskii</surname>
<given-names>A. I.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Significance Analysis of Spectral Count Data in Label-Free Shotgun Proteomics</article-title>. <source>Mol. Cell Proteomics</source> <volume>7</volume> (<issue>12</issue>), <fpage>2373</fpage>&#x2013;<lpage>2385</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M800203-MCP200</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fermin</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Tsou</surname>
<given-names>C.-C.</given-names>
</name>
<name>
<surname>Nesvizhskii</surname>
<given-names>A. I.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>QPROT: Statistical Method for Testing Differential Expression Using Protein-Level Intensity Data in Label-free Quantitative Proteomics</article-title>. <source>J.&#x20;Proteomics</source> <volume>129</volume>, <fpage>121</fpage>&#x2013;<lpage>126</lpage>. <comment>Elsevier</comment>. <pub-id pub-id-type="doi">10.1016/J.JPROT.2015.07.036</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Coelho</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Peterle</surname>
<given-names>G. T.</given-names>
</name>
<name>
<surname>Santos</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Agostini</surname>
<given-names>L. P.</given-names>
</name>
<name>
<surname>Maia</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Stur</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Keratins 17 and 19 Expression as Prognostic Markers in Oral Squamous Cell Carcinoma</article-title>. <source>Genet. Mol. Res.</source> <volume>14</volume> (<issue>4</issue>), <fpage>15123</fpage>&#x2013;<lpage>15132</lpage>. <pub-id pub-id-type="doi">10.4238/2015.November.24.21</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cooper</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Giancotti</surname>
<given-names>F. G.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance</article-title>. <source>Cancer Cell</source> <volume>35</volume> (<issue>3</issue>), <fpage>347</fpage>&#x2013;<lpage>367</lpage>. <pub-id pub-id-type="doi">10.1016/j.ccell.2019.01.007</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Costanza</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Rademaker</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Tiamiou</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>De Tullio</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Leenders</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Blomme</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Transforming Growth Factor Beta-Induced, an Extracellular Matrix Interacting Protein, Enhances Glycolysis and Promotes Pancreatic Cancer Cell Migration</article-title>. <source>Int. J.&#x20;Cancer</source> <volume>145</volume> (<issue>6</issue>), <fpage>1570</fpage>&#x2013;<lpage>1584</lpage>. <comment>Wiley-Liss Inc.</comment> <pub-id pub-id-type="doi">10.1002/ijc.32247</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Damiano</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Cress</surname>
<given-names>A. E.</given-names>
</name>
<name>
<surname>Hazlehurst</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Shtil</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Dalton</surname>
<given-names>W. S.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Cell Adhesion Mediated Drug Resistance (CAM-DR): Role of Integrins and Resistance to Apoptosis in Human Myeloma Cell Lines</article-title>. <source>Blood</source> <volume>93</volume> (<issue>5</issue>), <fpage>1658</fpage>&#x2013;<lpage>1667</lpage>. <pub-id pub-id-type="doi">10.1182/blood.v93.5.1658</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desgrosellier</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Cheresh</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Integrins in Cancer: Biological Implications and Therapeutic Opportunities</article-title>. <source>Nat. Rev. Cancer</source> <volume>10</volume> (<issue>1</issue>), <fpage>9</fpage>&#x2013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1038/nrc2748</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dickreuter</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Cordes</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Cancer Cell Adhesion Resistome: Mechanisms, Targeting and Translational Approaches</article-title>. <source>Biol. Chem.</source> <volume>398</volume> (<issue>7</issue>), <fpage>721</fpage>&#x2013;<lpage>735</lpage>. <pub-id pub-id-type="doi">10.1515/hsz-2016-0326</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doncheva</surname>
<given-names>N. T.</given-names>
</name>
<name>
<surname>Morris</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<name>
<surname>Gorodkin</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jensen</surname>
<given-names>L. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cytoscape StringApp: Network Analysis and Visualization of Proteomics Data</article-title>. <source>J.&#x20;Proteome Res.</source> <volume>18</volume> (<issue>2</issue>), <fpage>623</fpage>&#x2013;<lpage>632</lpage>. <comment>American Chemical Society</comment>. <pub-id pub-id-type="doi">10.1021/acs.jproteome.8b00702</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Echarri</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Del Pozo</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Caveolae Internalization Regulates Integrin-Dependent Signaling Pathways</article-title>. <source>Cell Cycle</source> <volume>5</volume> (<issue>19</issue>), <fpage>2179</fpage>&#x2013;<lpage>2182</lpage>. <pub-id pub-id-type="doi">10.4161/cc.5.19.3264</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Felding-Habermann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Cheresh</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Vitronectin and its Receptors</article-title>. <source>Curr. Opin. Cel Biol.</source> <volume>5</volume> (<issue>5</issue>), <fpage>864</fpage>&#x2013;<lpage>868</lpage>. <pub-id pub-id-type="doi">10.1016/0955-0674(93)90036-P</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Dirrig</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Owaribe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kedinger</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>J.&#x20;F.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Polarized Expression of HD1: Relationship with the Cytoskeleton in Cultured Human Colonic Carcinoma Cells</article-title>. <source>Exp. Cel Res.</source> <volume>231</volume> (<issue>2</issue>), <fpage>319</fpage>&#x2013;<lpage>327</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1996.3465</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fontao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Stutzmann</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Gendry</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Launay</surname>
<given-names>J.&#x20;F.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Regulation of the Type II Hemidesmosomal Plaque Assembly in Intestinal Epithelial Cells</article-title>. <source>Exp. Cel Res.</source> <volume>250</volume> (<issue>2</issue>), <fpage>298</fpage>&#x2013;<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1006/excr.1999.4549</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gasca</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Flores</surname>
<given-names>M. L.</given-names>
</name>
<name>
<surname>Jim&#xe9;nez-Guerrero</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>S&#xe1;ez</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Barrag&#xe1;n</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Ru&#xed;z-Borrego</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>EDIL3 Promotes Epithelial-Mesenchymal Transition and Paclitaxel Resistance through its Interaction with Integrin &#x3b1;V&#x3b2;3 in Cancer Cells</article-title>. <source>Cell Death Discov.</source> <volume>6</volume> (<issue>1</issue>), <fpage>86</fpage>. <pub-id pub-id-type="doi">10.1038/s41420-020-00322-x</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ginos</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Michalowicz</surname>
<given-names>B. S.</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>K. J.</given-names>
</name>
<name>
<surname>Volker</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Pambuccian</surname>
<given-names>S. E.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Identification of a Gene Expression Signature Associated with Recurrent Disease in Squamous Cell Carcinoma of the Head and Neck</article-title>. <source>Cancer Res.</source> <volume>64</volume> (<issue>1</issue>), <fpage>55</fpage>&#x2013;<lpage>63</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-03-2144</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goletz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zillikens</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Structural Proteins of the Dermal-Epidermal Junction Targeted by Autoantibodies in Pemphigoid Diseases</article-title>. <source>Exp. Dermatol.</source> <volume>26</volume> (<issue>12</issue>), <fpage>1154</fpage>&#x2013;<lpage>1162</lpage>. <pub-id pub-id-type="doi">10.1111/exd.13446</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Weijie</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Feng</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liuxing</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Mengquan</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Critical Role of miR-10b in Transforming Growth Factor-&#x392;1-Induced Epithelial-Mesenchymal Transition in Breast Cancer</article-title>. <source>Cancer Gene Ther.</source> <volume>21</volume> (<issue>2</issue>), <fpage>60</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1038/cgt.2013.82</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hasegawa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cheng</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Maruyama</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamazaki</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ab&#xe9;</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Babkair</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Differential Immunohistochemical Expression Profiles of Perlecan-Binding Growth Factors in Epithelial Dysplasia, Carcinoma <italic>In Situ</italic>, and Squamous Cell Carcinoma of the Oral Mucosa</article-title>. <source>Pathol. - Res. Pract.</source> <volume>212</volume> (<issue>5</issue>), <fpage>426</fpage>&#x2013;<lpage>436</lpage>. <pub-id pub-id-type="doi">10.1016/j.prp.2016.02.016</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hatzfeld</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Magin</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Cross-Talk between Hemidesmosomes and Focal Adhesions: A Primer for Wound Healing, Blistering Skin Disease, and Skin Aging</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>139</volume> (<issue>9</issue>), <fpage>1854</fpage>&#x2013;<lpage>1856</lpage>. <pub-id pub-id-type="doi">10.1016/j.jid.2019.04.010</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hayashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Madri</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Yurchenco</surname>
<given-names>P. D.</given-names>
</name>
</person-group> (<year>1992</year>). <article-title>Endothelial Cells Interact with the Core Protein of Basement Membrane Perlecan through Beta 1 and Beta 3 Integrins: An Adhesion Modulated by Glycosaminoglycan</article-title>. <source>J.&#x20;Cel Biol.</source> <volume>119</volume> (<issue>4</issue>), <fpage>945</fpage>&#x2013;<lpage>959</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.119.4.945</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Herold-Mende</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Kartenbeck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tomakidi</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Bosch</surname>
<given-names>F. X.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Metastatic Growth of Squamous Cell Carcinomas Is Correlated with Upregulation and Redistribution of Hemidesmosomal Components</article-title>. <source>Cell Tissue Res</source> <volume>306</volume> (<issue>3</issue>), <fpage>399</fpage>&#x2013;<lpage>408</lpage>. <pub-id pub-id-type="doi">10.1007/s004410100462</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hidai</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zupancic</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Penta</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mikhail</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kawana</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Quertermous</surname>
<given-names>E. E.</given-names>
</name>
<etal/>
</person-group> (<year>1998</year>). <article-title>Cloning and Characterization of Developmental Endothelial Locus-1: An Embryonic Endothelial Cell Protein that Binds the &#x3b1;v&#x3b2;3 Integrin Receptor</article-title>. <source>Genes Dev.</source> <volume>12</volume> (<issue>1</issue>), <fpage>21</fpage>&#x2013;<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1101/gad.12.1.21</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hodge</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Have</surname>
<given-names>S. T.</given-names>
</name>
<name>
<surname>Hutton</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lamond</surname>
<given-names>A. I.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Cleaning up the Masses: Exclusion Lists to Reduce Contamination with HPLC-MS/MS</article-title>. <source>J.&#x20;Proteomics</source> <volume>88</volume>, <fpage>92</fpage>&#x2013;<lpage>103</lpage>. <pub-id pub-id-type="doi">10.1016/j.jprot.2013.02.023</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Horton</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Byron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Askari</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Ng</surname>
<given-names>D. H. J.</given-names>
</name>
<name>
<surname>Millon-Fr&#xe9;millon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Definition of a Consensus Integrin Adhesome and its Dynamics during Adhesion Complex Assembly and Disassembly</article-title>. <source>Nat. Cel Biol</source> <volume>17</volume> (<issue>12</issue>), <fpage>1577</fpage>&#x2013;<lpage>1587</lpage>. <pub-id pub-id-type="doi">10.1038/ncb3257</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2009a</year>). <article-title>Bioinformatics Enrichment Tools: Paths toward the Comprehensive Functional Analysis of Large Gene Lists</article-title>. <source>Nucleic Acids Res.</source> <volume>37</volume> (<issue>1</issue>), <fpage>1</fpage>&#x2013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkn923</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Sherman</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Lempicki</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2009b</year>). <article-title>Systematic and Integrative Analysis of Large Gene Lists Using DAVID Bioinformatics Resources</article-title>. <source>Nat. Protoc.</source> <volume>4</volume> (<issue>1</issue>), <fpage>44</fpage>&#x2013;<lpage>57</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2008.211</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Byron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bass</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Craig</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Pinney</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Knight</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Proteomic Analysis of Integrin-Associated Complexes Identifies RCC2 as a Dual Regulator of Rac1 and Arf6</article-title>. <source>Sci. Signal.</source> <volume>2</volume> (<issue>87</issue>), <fpage>ra51</fpage>. <pub-id pub-id-type="doi">10.1126/scisignal.2000396</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Chastney</surname>
<given-names>M. R.</given-names>
</name>
<name>
<surname>Askari</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>M. J.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Signal Transduction via Integrin Adhesion Complexes</article-title>. <source>Curr. Opin. Cel Biol.</source> <volume>56</volume>, <fpage>14</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.ceb.2018.08.004</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hynes</surname>
<given-names>R. O.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>Integrins: Bidirectional, Allosteric Signaling Machines</article-title>. <source>Cell</source> <volume>110</volume> (<issue>6</issue>), <fpage>673</fpage>&#x2013;<lpage>687</lpage>. <pub-id pub-id-type="doi">10.1016/s0092-8674(02)00971-6</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iguchi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ishihara</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Uchida</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Tajima</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mizutani</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Kawabata</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Filamin B Enhances the Invasiveness of Cancer Cells into 3D Collagen Matrices</article-title>. <source>Cell Struct. Funct.</source> <volume>40</volume> (<issue>2</issue>), <fpage>61</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1247/csf.15001</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jeong</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Ban</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Oh</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Jin Lee</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yong Park</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Koh</surname>
<given-names>Y. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Prognostic Significance of EDIL3 Expression and Correlation with Mesenchymal Phenotype and Microvessel Density in Lung Adenocarcinoma</article-title>. <source>Sci. Rep.</source> <volume>7</volume> (<issue>1</issue>), <fpage>8649</fpage>. <pub-id pub-id-type="doi">10.1038/s41598-017-08851-9</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Overexpression of HTRA1 Leads to Down-Regulation of Fibronectin and Functional Changes in RF/6A Cells and HUVECs</article-title>. <source>PLoS ONE</source> <volume>7</volume> (<issue>10</issue>), <fpage>e46115</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0046115</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jones</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Byron</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Millon-Fr&#xe9;millon</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Robertson</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Paul</surname>
<given-names>N. R.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Isolation of Integrin-Based Adhesion Complexes</article-title>. <source>Curr. Protoc. Cel Biol.</source> <volume>66</volume>, <fpage>1</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1002/0471143030.cb0908s66</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Hsiao</surname>
<given-names>C.-T.</given-names>
</name>
<name>
<surname>Yates III</surname>
<given-names>J.&#x20;R.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Waterman</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Analysis of the Myosin-II-Responsive Focal Adhesion Proteome Reveals a Role for &#x3b2;-Pix in Negative Regulation of Focal Adhesion Maturation</article-title>. <source>Nat. Cel Biol</source> <volume>13</volume> (<issue>4</issue>), <fpage>383</fpage>&#x2013;<lpage>393</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2216</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuo</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yates</surname>
<given-names>J.&#x20;R.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Waterman</surname>
<given-names>C. M.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Isolation of Focal Adhesion Proteins for Biochemical and Proteomic Analysis</article-title>. <source>Methods Mol. Biol.</source> <volume>757</volume>, <fpage>297</fpage>&#x2013;<lpage>323</lpage>. <pub-id pub-id-type="doi">10.1007/978-1-61779-166-6_19</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lau</surname>
<given-names>L. F.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Cell Surface Receptors for CCN Proteins</article-title>. <source>J.&#x20;Cel Commun. Signal.</source> <volume>10</volume> (<issue>2</issue>), <fpage>121</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1007/s12079-016-0324-z</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>J.-H.</given-names>
</name>
<name>
<surname>Jang</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Seo</surname>
<given-names>H. L.</given-names>
</name>
<name>
<surname>Ku</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>S. S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Sauchinone Attenuates Liver Fibrosis and Hepatic Stellate Cell Activation through TGF-&#x3b2;/Smad Signaling Pathway</article-title>. <source>Chemico-Biological Interactions</source> <volume>224</volume>, <fpage>58</fpage>&#x2013;<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.cbi.2014.10.005</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Litjens</surname>
<given-names>S. H. M.</given-names>
</name>
<name>
<surname>de Pereda</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Current Insights into the Formation and Breakdown of Hemidesmosomes</article-title>. <source>Trends Cel Biol.</source> <volume>16</volume> (<issue>7</issue>), <fpage>376</fpage>&#x2013;<lpage>383</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2006.05.004</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lock</surname>
<given-names>J.&#x20;G.</given-names>
</name>
<name>
<surname>Baschieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Montagnac</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Str&#xf6;mblad</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Clathrin-Containing Adhesion Complexes</article-title>. <source>J.&#x20;Cel Biol.</source> <volume>218</volume> (<issue>7</issue>), <fpage>2086</fpage>&#x2013;<lpage>2095</lpage>. <pub-id pub-id-type="doi">10.1083/jcb.201811160</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lock</surname>
<given-names>J.&#x20;G.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>M. C.</given-names>
</name>
<name>
<surname>Askari</surname>
<given-names>J.&#x20;A.</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Oddone</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Olofsson</surname>
<given-names>H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Reticular Adhesions Are a Distinct Class of Cell-Matrix Adhesions that Mediate Attachment during Mitosis</article-title>. <source>Nat. Cel Biol</source> <volume>20</volume> (<issue>11</issue>), <fpage>1290</fpage>&#x2013;<lpage>1302</lpage>. <pub-id pub-id-type="doi">10.1038/s41556-018-0220-2</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Loschke</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Homberg</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Magin</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Keratin Isotypes Control Desmosome Stability and Dynamics through PKC&#x3b1;</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>136</volume> (<issue>1</issue>), <fpage>202</fpage>&#x2013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1038/JID.2015.403</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Majhen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Stojanovi&#x107;</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Vuki&#x107;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Pichon</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Leduc</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Osmak</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Increased Adenovirus Type 5 Mediated Transgene Expression Due to RhoB Down-Regulation</article-title>. <source>PLoS ONE</source> <volume>9</volume> (<issue>1</issue>), <fpage>e86698</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0086698</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McGrath</surname>
<given-names>J.&#x20;A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Recently Identified Forms of Epidermolysis Bullosa</article-title>. <source>Ann. Dermatol.</source> <volume>27</volume> (<issue>6</issue>), <fpage>658</fpage>&#x2013;<lpage>666</lpage>. <pub-id pub-id-type="doi">10.5021/ad.2015.27.6.658</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meireles Da Costa</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mendes</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Pontes</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Nasciutti</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Ribeiro Pinto</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Palumbo J&#xfa;nior</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>Potential Therapeutic Significance of Laminin in Head and Neck Squamous Carcinomas</article-title>. <source>Cancers</source> <volume>13</volume>, <fpage>1890</fpage>. <pub-id pub-id-type="doi">10.3390/cancers13081890</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Midwood</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Chiquet</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tucker</surname>
<given-names>R. P.</given-names>
</name>
<name>
<surname>Orend</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Tenascin-C at a Glance</article-title>. <source>J.&#x20;Cel Sci.</source> <volume>129</volume> (<issue>23</issue>), <fpage>4321</fpage>&#x2013;<lpage>4327</lpage>. <comment>Company of Biologists Ltd</comment>. <pub-id pub-id-type="doi">10.1242/jcs.190546</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Myllym&#xe4;ki</surname>
<given-names>S.-M.</given-names>
</name>
<name>
<surname>K&#xe4;m&#xe4;r&#xe4;inen</surname>
<given-names>U.-R.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Cruz</surname>
<given-names>S. P.</given-names>
</name>
<name>
<surname>Miettinen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Vuorela</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Assembly of the &#x3b2;4-Integrin Interactome Based on Proximal Biotinylation in the Presence and Absence of Heterodimerization&#x2a;</article-title>. <source>Mol. Cell Proteomics</source> <volume>18</volume> (<issue>2</issue>), <fpage>277</fpage>&#x2013;<lpage>293</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.RA118.001095</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nesvizhskii</surname>
<given-names>A. I.</given-names>
</name>
<name>
<surname>Keller</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kolker</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Aebersold</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>A Statistical Model for Identifying Proteins by Tandem Mass Spectrometry</article-title>. <source>Anal. Chem.</source> <volume>75</volume> (<issue>17</issue>), <fpage>4646</fpage>&#x2013;<lpage>4658</lpage>. <pub-id pub-id-type="doi">10.1021/ac0341261</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishimori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Tomonaga</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Matsushita</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Oh-Ishi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kodera</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2006</year>). <article-title>Proteomic Analysis of Primary Esophageal Squamous Cell Carcinoma Reveals Downregulation of a Cell Adhesion Protein, Periplakin</article-title>. <source>Proteomics</source> <volume>6</volume> (<issue>3</issue>), <fpage>1011</fpage>&#x2013;<lpage>1018</lpage>. <pub-id pub-id-type="doi">10.1002/pmic.200500262</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Owaribe</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kartenbeck</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Stumpp</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Magin</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Krieg</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Diaz</surname>
<given-names>L. A.</given-names>
</name>
<etal/>
</person-group> (<year>1990</year>). <article-title>The Hemidesmosomal Plaque</article-title>. <source>Differentiation</source> <volume>45</volume> (<issue>3</issue>), <fpage>207</fpage>&#x2013;<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1111/j.1432-0436.1990.tb00475.x</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parad&#x17e;ik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Stojanovi&#x107;</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nesti&#x107;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Majhen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dekani&#x107;</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>KANK2 Links &#x3b1;V&#x3b2;5 Focal Adhesions to Microtubules and Regulates Sensitivity to Microtubule Poisons and Cell Migration</article-title>. <source>Front. Cel Dev. Biol.</source> <volume>8</volume>, <fpage>1</fpage>&#x2013;<lpage>17</lpage>. <pub-id pub-id-type="doi">10.3389/fcell.2020.00125</pub-id> </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peretti</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Angelini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Savalli</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Florio</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yuspa</surname>
<given-names>S. H.</given-names>
</name>
<name>
<surname>Mazzanti</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Chloride Channels in Cancer: Focus on Chloride Intracellular Channel 1 and 4 (CLIC1 and CLIC4) Proteins in Tumor Development and as Novel Therapeutic Targets</article-title>. <source>Biochim. Biophys. Acta (Bba) - Biomembranes</source> <volume>1848</volume> (<issue>10 Pt B</issue>), <fpage>2523</fpage>&#x2013;<lpage>2531</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamem.2014.12.012</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pora</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yoon</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Windoffer</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Leube</surname>
<given-names>R. E.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Hemidesmosomes and Focal Adhesions Treadmill as Separate but Linked Entities during Keratinocyte Migration</article-title>. <source>J.&#x20;Invest. Dermatol.</source> <volume>139</volume> (<issue>9</issue>), <fpage>1876</fpage>&#x2013;<lpage>1888</lpage>. <comment>e4</comment>. <pub-id pub-id-type="doi">10.1016/j.jid.2019.03.1139</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pouliot</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kusuma</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Laminin-511Cell Adhesion and Migration</article-title>. <source>Cell Adhes. Migration</source> <volume>7</volume> (<issue>1</issue>), <fpage>142</fpage>&#x2013;<lpage>149</lpage>. <pub-id pub-id-type="doi">10.4161/cam.22125</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Quick</surname>
<given-names>Q.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Microtubule-actin Crosslinking Factor 1 and Plakins as Therapeutic Drug Targets</article-title>. <source>Int. J.&#x20;Mol. Sci. MDPI AG</source> <volume>19</volume> (<issue>2</issue>), <fpage>368</fpage>. <pub-id pub-id-type="doi">10.3390/ijms19020368</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raab-Westphal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Raab-Westphal</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Marshall</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Goodman</surname>
<given-names>S. L.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Integrins as Therapeutic Targets: Successes and Cancers</article-title>. <source>Cancers</source> <volume>9</volume> (<issue>12</issue>), <fpage>110</fpage>. <pub-id pub-id-type="doi">10.3390/cancers9090110</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ramovs</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>te Molder</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Opposing Roles of Laminin-Binding Integrins in Cancer</article-title>. <source>Matrix Biol.</source> <volume>57-58</volume> (<issue>58</issue>), <fpage>213</fpage>&#x2013;<lpage>243</lpage>. <pub-id pub-id-type="doi">10.1016/j.matbio.2016.08.007</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Samar&#x17e;ija</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Dekani&#x107;</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>J.&#x20;D.</given-names>
</name>
<name>
<surname>Parad&#x17e;ik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stojanovi&#x107;</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Humphries</surname>
<given-names>M. J.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Integrin Crosstalk Contributes to the Complexity of Signalling and Unpredictable Cancer Cell Fates</article-title>. <source>Cancers</source> <volume>12</volume> (<issue>7</issue>), <fpage>1910</fpage>&#x2013;<lpage>1926</lpage>. <pub-id pub-id-type="doi">10.3390/cancers12071910</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schiller</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Friedel</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Boulegue</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>F&#xe4;ssler</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Quantitative Proteomics of the Integrin Adhesome Show a Myosin II-Dependent Recruitment of LIM Domain Proteins</article-title>. <source>EMBO Rep.</source> <volume>12</volume> (<issue>3</issue>), <fpage>259</fpage>&#x2013;<lpage>266</lpage>. <pub-id pub-id-type="doi">10.1038/embor.2011.5</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Seguin</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Desgrosellier</surname>
<given-names>J.&#x20;S.</given-names>
</name>
<name>
<surname>Weis</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Cheresh</surname>
<given-names>D. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Integrins and Cancer: Regulators of Cancer Stemness, Metastasis, and Drug Resistance</article-title>. <source>Trends Cel Biol.</source> <volume>25</volume> (<issue>4</issue>), <fpage>234</fpage>&#x2013;<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1016/j.tcb.2014.12.006</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shannon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Markiel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozier</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Baliga</surname>
<given-names>N. S.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.&#x20;T.</given-names>
</name>
<name>
<surname>Ramage</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks</article-title>. <source>Genome Res.</source> <volume>13</volume> (<issue>11</issue>), <fpage>2498</fpage>&#x2013;<lpage>2504</lpage>. <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stojanovi&#x107;</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Brozovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Majhen</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Bosnar</surname>
<given-names>M. H.</given-names>
</name>
<name>
<surname>Fritz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Osmak</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Integrin &#x3b1;v&#x3b2;3 Expression in Tongue Squamous Carcinoma Cells Cal27 Confers Anticancer Drug Resistance through Loss of pSrc(Y418)</article-title>. <source>Biochim. Biophys. Acta (Bba) - Mol. Cel Res.</source> <volume>1863</volume> (<issue>8</issue>), <fpage>1969</fpage>&#x2013;<lpage>1978</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2016.04.019</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Supek</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Bo&#x161;njak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>&#x160;kunca</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>&#x160;muc</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Revigo Summarizes and Visualizes Long Lists of Gene Ontology Terms</article-title>. <source>PLoS ONE</source> <volume>6</volume> (<issue>7</issue>), <fpage>e21800</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0021800</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szklarczyk</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Gable</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>Lyon</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Junge</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wyder</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Huerta-Cepas</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>STRING V11: Protein-Protein Association Networks with Increased Coverage, Supporting Functional Discovery in Genome-Wide Experimental Datasets</article-title>. <source>Nucleic Acids Res.</source> <volume>47</volume> (<issue>D1</issue>), <fpage>D607</fpage>&#x2013;<lpage>D613</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gky1131</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Te Molder</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Juksar</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Harkes</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kreft</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Tetraspanin CD151 and Integrin &#x3b1;3&#x3b2;1 Contribute to the Stabilization of Integrin &#x3b1;6&#x3b2;4-Containing Cell-Matrix Adhesions</article-title>. <source>J.&#x20;Cel. Sci.</source> <volume>132</volume> (<issue>19</issue>), <fpage>jcs235366</fpage>. <pub-id pub-id-type="doi">10.1242/jcs.235366</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Todorovi&#x107;</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Desai</surname>
<given-names>B. V.</given-names>
</name>
<name>
<surname>Eigenheer</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Amargo</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Mrksich</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Detection of Differentially Expressed Basal Cell Proteins by Mass Spectrometry</article-title>. <source>Mol. Cell Proteomics</source> <volume>9</volume> (<issue>2</issue>), <fpage>351</fpage>&#x2013;<lpage>361</lpage>. <pub-id pub-id-type="doi">10.1074/mcp.M900358-MCP200</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turashvili</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Bouchal</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Baumforth</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Dziechciarkova</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ehrmann</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Novel Markers for Differentiation of Lobular and Ductal Invasive Breast Carcinomas by Laser Microdissection and Microarray Analysis</article-title>. <source>BMC Cancer</source> <volume>7</volume>, <fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2407-7-55</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Uematsu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nishizawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Owaribe</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Demonstration of Type II Hemidesmosomes in a Mammary Gland Epithelial Cell Line, BMGE-H1</article-title>. <source>J.&#x20;Biochem.</source> <volume>115</volume> (<issue>3</issue>), <fpage>469</fpage>&#x2013;<lpage>476</lpage>. <pub-id pub-id-type="doi">10.1093/oxfordjournals.jbchem.a124361</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walko</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Casta&#xf1;&#xf3;n</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Wiche</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Molecular Architecture and Function of the Hemidesmosome</article-title>. <source>Cel Tissue Res</source> <volume>360</volume> (<issue>3</issue>), <fpage>529</fpage>&#x2013;<lpage>544</lpage>. <pub-id pub-id-type="doi">10.1007/s00441-014-2061-z</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C. F.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Annexin A2: Its Molecular Regulation and Cellular Expression in Cancer Development</article-title>. <source>Dis. Markers</source>. <pub-id pub-id-type="doi">10.1155/2014/308976</pub-id> </citation>
</ref>
<ref id="B83">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Zuidema</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Te Molder</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Nahidiazar</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Hoekman</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Hemidesmosomes Modulate Force Generation via Focal Adhesions</article-title>. <source>J.&#x20;Cel. Biol.</source> <volume>219</volume> (<issue>2</issue>), <fpage>e201904137</fpage>. <pub-id pub-id-type="doi">10.1083/jcb.201904137</pub-id> </citation>
</ref>
<ref id="B84">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ween</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Oehler</surname>
<given-names>M. K.</given-names>
</name>
<name>
<surname>Ricciardelli</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Transforming Growth Factor-Beta-Induced Protein (TGFBI)/(&#x3b2;ig-H3): A Matrix Protein with Dual Functions in Ovarian Cancer</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>13</volume> (<issue>8</issue>), <fpage>10461</fpage>&#x2013;<lpage>10477</lpage>. <comment>Multidisciplinary Digital Publishing Institute (MDPI)</comment>. <pub-id pub-id-type="doi">10.3390/ijms130810461</pub-id> </citation>
</ref>
<ref id="B85">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wesley</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Berzins</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kannourakis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>N.</given-names>
</name>
</person-group> (<year>2021</year>). <article-title>The Attributes of Plakins in Cancer and Disease: Perspectives on Ovarian Cancer Progression, Chemoresistance and Recurrence</article-title>. <source>Cell Commun Signal</source> <volume>19</volume> (<issue>1</issue>), <fpage>55</fpage>. <pub-id pub-id-type="doi">10.1186/s12964-021-00726-x</pub-id> </citation>
</ref>
<ref id="B86">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willett</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pollard</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Vlasak</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Morley</surname>
<given-names>S. J.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Localization of Ribosomes and Translation Initiation Factors to Talin/&#x3b2;3-Integrin-Enriched Adhesion Complexes in Spreading and Migrating Mammalian Cells</article-title>. <source>Biol. Cel</source> <volume>102</volume> (<issue>5</issue>), <fpage>265</fpage>&#x2013;<lpage>276</lpage>. <pub-id pub-id-type="doi">10.1042/BC20090141</pub-id> </citation>
</ref>
<ref id="B87">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Winograd-Katz</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>F&#xe4;ssler</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Legate</surname>
<given-names>K. R.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Integrin Adhesome: From Genes and Proteins to Human Disease</article-title>. <source>Nat. Rev. Mol. Cel Biol</source> <volume>15</volume> (<issue>4</issue>), <fpage>273</fpage>&#x2013;<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3769</pub-id> </citation>
</ref>
<ref id="B88">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Woychek</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kligys</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Hopkinson</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>J.&#x20;C. R.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>The 3&#x2032;UTR of the &#x3b1;6 Integrin Message Regulates Localization of &#x3b1;6&#x3b2;4 Integrin Heterodimers</article-title>. <source>Biochem. Biophysical Res. Commun.</source> <volume>513</volume> (<issue>1</issue>), <fpage>8</fpage>&#x2013;<lpage>14</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2019.03.116</pub-id> </citation>
</ref>
<ref id="B89">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yadav</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Datta</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Teknos</surname>
<given-names>T. N.</given-names>
</name>
<name>
<surname>Kumar</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial-Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway</article-title>. <source>Mol. Cancer Res.</source> <volume>9</volume> (<issue>12</issue>), <fpage>1658</fpage>&#x2013;<lpage>1667</lpage>. <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-11-0271</pub-id> </citation>
</ref>
<ref id="B90">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamashiro</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Thang</surname>
<given-names>B. Q.</given-names>
</name>
<name>
<surname>Ramirez</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Kohata</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ohata</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Matrix Mechanotransduction Mediated by Thrombospondin-1/integrin/YAP in the Vascular Remodeling</article-title>. <source>Proc. Natl. Acad. Sci. USA</source> <volume>117</volume> (<issue>18</issue>), <fpage>9896</fpage>&#x2013;<lpage>9905</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1919702117</pub-id> </citation>
</ref>
<ref id="B91">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yuh</surname>
<given-names>D.-Y.</given-names>
</name>
<name>
<surname>Maekawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kajikawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bdeir</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Chavakis</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>The Secreted Protein DEL-1 Activates a &#x3b2;3 Integrin-FAK-Erk1/2-RUNX2 Pathway and Promotes Osteogenic Differentiation and Bone Regeneration</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>295</volume> (<issue>21</issue>), <fpage>7261</fpage>&#x2013;<lpage>7273</lpage>. <comment>American Society for Biochemistry and Molecular Biology Inc</comment>. <pub-id pub-id-type="doi">10.1074/jbc.RA120.013024</pub-id> </citation>
</ref>
<ref id="B92">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zaidel-Bar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Itzkovitz</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ma&#x27;ayan</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Iyengar</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Functional Atlas of the Integrin Adhesome</article-title>. <source>Nat. Cel Biol</source> <volume>9</volume> (<issue>8</issue>), <fpage>858</fpage>&#x2013;<lpage>867</lpage>. <pub-id pub-id-type="doi">10.1038/ncb0807-858</pub-id> </citation>
</ref>
<ref id="B93">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamir</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Katz</surname>
<given-names>B. Z.</given-names>
</name>
<name>
<surname>Aota</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Geiger</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Kam</surname>
<given-names>Z.</given-names>
</name>
</person-group> (<year>1999</year>). <article-title>Molecular Diversity of Cell-Matrix Adhesions</article-title>. <source>J.&#x20;Cel Sci</source> <volume>112</volume> (<issue>Pt 11</issue>), <fpage>1655</fpage>&#x2013;<lpage>1669</lpage>. <pub-id pub-id-type="doi">10.1242/jcs.112.11.1655</pub-id> </citation>
</ref>
<ref id="B94">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuidema</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Sonnenberg</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Crosstalk Between Cell Adhesion Complexes in Regulation of Mechanotransduction</article-title>. <source>BioEssays</source> <volume>42</volume>, <fpage>2000119</fpage>. <pub-id pub-id-type="doi">10.1002/bies.202000119</pub-id> </citation>
</ref>
</ref-list>
<sec id="s11">
<title>Glossary</title>
<def-list>
<def-item>
<term id="G1-fcell.2021.786758">
<bold>ACTN1</bold>
</term>
<def>
<p>&#x3b1;-actinin&#x20;1</p>
</def>
</def-item>
<def-item>
<term id="G2-fcell.2021.786758">
<bold>ACTN4</bold>
</term>
<def>
<p>&#x3b1;-actinin 4</p>
</def>
</def-item>
<def-item>
<term id="G3-fcell.2021.786758">
<bold>AHNAK</bold>
</term>
<def>
<p>neuroblast differentiation-associated protein</p>
</def>
</def-item>
<def-item>
<term id="G4-fcell.2021.786758">
<bold>ANOVA</bold>
</term>
<def>
<p>related-measure two-way analysis of variance</p>
</def>
</def-item>
<def-item>
<term id="G5-fcell.2021.786758">
<bold>ANXA1/2</bold>
</term>
<def>
<p>annexins A1 and&#x20;2</p>
</def>
</def-item>
<def-item>
<term id="G6-fcell.2021.786758">
<bold>BM</bold>
</term>
<def>
<p>basement membrane</p>
</def>
</def-item>
<def-item>
<term id="G7-fcell.2021.786758">
<bold>BP180</bold>
</term>
<def>
<p>BPAG2 or collagen&#x20;XVII</p>
</def>
</def-item>
<def-item>
<term id="G8-fcell.2021.786758">
<bold>BP230</bold>
</term>
<def>
<p>dystonin or BPAG1-e</p>
</def>
</def-item>
<def-item>
<term id="G9-fcell.2021.786758">
<bold>Cal27</bold>
</term>
<def>
<p>tongue squamous carcinoma cells</p>
</def>
</def-item>
<def-item>
<term id="G10-fcell.2021.786758">
<bold>CAV1</bold>
</term>
<def>
<p>caveolin-1</p>
</def>
</def-item>
<def-item>
<term id="G11-fcell.2021.786758">
<bold>CD151</bold>
</term>
<def>
<p>tetraspanin</p>
</def>
</def-item>
<def-item>
<term id="G12-fcell.2021.786758">
<bold>cDDP</bold>
</term>
<def>
<p>cisplatin</p>
</def>
</def-item>
<def-item>
<term id="G13-fcell.2021.786758">
<bold>CLIC1</bold>
</term>
<def>
<p>chloride intracellular channel&#x20;1</p>
</def>
</def-item>
<def-item>
<term id="G14-fcell.2021.786758">
<bold>COL7A1</bold>
</term>
<def>
<p>collagen VII</p>
</def>
</def-item>
<def-item>
<term id="G15-fcell.2021.786758">
<bold>CYR61</bold>
</term>
<def>
<p>cysteine-rich&#x20;61</p>
</def>
</def-item>
<def-item>
<term id="G16-fcell.2021.786758">
<bold>DAVID</bold>
</term>
<def>
<p>database for annotation, visualization, and integrated discovery</p>
</def>
</def-item>
<def-item>
<term id="G17-fcell.2021.786758">
<bold>DDX</bold>
</term>
<def>
<p>DEAD box proteins</p>
</def>
</def-item>
<def-item>
<term id="G18-fcell.2021.786758">
<bold>DMEM</bold>
</term>
<def>
<p>Dulbecco&#x2019;s modified Eagle&#x2019;s medium</p>
</def>
</def-item>
<def-item>
<term id="G19-fcell.2021.786758">
<bold>DMSO</bold>
</term>
<def>
<p>dimethyl sulfoxide</p>
</def>
</def-item>
<def-item>
<term id="G20-fcell.2021.786758">
<bold>DOX</bold>
</term>
<def>
<p>doxorubicine</p>
</def>
</def-item>
<def-item>
<term id="G21-fcell.2021.786758">
<bold>DSG2</bold>
</term>
<def>
<p>desmoglein 2</p>
</def>
</def-item>
<def-item>
<term id="G22-fcell.2021.786758">
<bold>DSG3</bold>
</term>
<def>
<p>desmoglein 3</p>
</def>
</def-item>
<def-item>
<term id="G23-fcell.2021.786758">
<bold>DSP</bold>
</term>
<def>
<p>desmoplakin</p>
</def>
</def-item>
<def-item>
<term id="G24-fcell.2021.786758">
<bold>DTBP</bold>
</term>
<def>
<p>dimethyl 3,3&#x27;-dithiobispropionimidate, Wang and Richard&#x27;s reagent</p>
</def>
</def-item>
<def-item>
<term id="G25-fcell.2021.786758">
<bold>ECM</bold>
</term>
<def>
<p>extracellular matrix</p>
</def>
</def-item>
<def-item>
<term id="G26-fcell.2021.786758">
<bold>EDIL-3</bold>
</term>
<def>
<p>EGF-like repeat and discoidin I-like domain-containing protein&#x20;3</p>
</def>
</def-item>
<def-item>
<term id="G27-fcell.2021.786758">
<bold>EDTA</bold>
</term>
<def>
<p>ethylenediaminetetraacetic&#x20;acid</p>
</def>
</def-item>
<def-item>
<term id="G28-fcell.2021.786758">
<bold>EMT</bold>
</term>
<def>
<p>epithelial&#x2013;mesenchymal transition</p>
</def>
</def-item>
<def-item>
<term id="G29-fcell.2021.786758">
<bold>FA</bold>
</term>
<def>
<p>focal adhesion</p>
</def>
</def-item>
<def-item>
<term id="G30-fcell.2021.786758">
<bold>FAK</bold>
</term>
<def>
<p>focal adhesion kinase</p>
</def>
</def-item>
<def-item>
<term id="G31-fcell.2021.786758">
<bold>FBS</bold>
</term>
<def>
<p>foetal bovine serum</p>
</def>
</def-item>
<def-item>
<term id="G32-fcell.2021.786758">
<bold>FLNA</bold>
</term>
<def>
<p>filamin A</p>
</def>
</def-item>
<def-item>
<term id="G33-fcell.2021.786758">
<bold>FLNB</bold>
</term>
<def>
<p>filamin B</p>
</def>
</def-item>
<def-item>
<term id="G34-fcell.2021.786758">
<bold>FN</bold>
</term>
<def>
<p>fibronectin</p>
</def>
</def-item>
<def-item>
<term id="G35-fcell.2021.786758">
<bold>HEPES</bold>
</term>
<def>
<p>hydroxyethyl piperazineethanesulfonic&#x20;acid</p>
</def>
</def-item>
<def-item>
<term id="G36-fcell.2021.786758">
<bold>HD</bold>
</term>
<def>
<p>hemidesmosome</p>
</def>
</def-item>
<def-item>
<term id="G37-fcell.2021.786758">
<bold>HNSCC</bold>
</term>
<def>
<p>head and neck squamous cell carcinoma</p>
</def>
</def-item>
<def-item>
<term id="G38-fcell.2021.786758">
<bold>HSPG 2</bold>
</term>
<def>
<p>heparan sulphate proteoglycan 2 or perlecan</p>
</def>
</def-item>
<def-item>
<term id="G39-fcell.2021.786758">
<bold>HTRA-1</bold>
</term>
<def>
<p>high-temperature requirement serine protease</p>
</def>
</def-item>
<def-item>
<term id="G40-fcell.2021.786758">
<bold>IAC</bold>
</term>
<def>
<p>integrin adhesion complex</p>
</def>
</def-item>
<def-item>
<term id="G41-fcell.2021.786758">
<bold>IF</bold>
</term>
<def>
<p>immunofluorescence</p>
</def>
</def-item>
<def-item>
<term id="G42-fcell.2021.786758">
<bold>ILK</bold>
</term>
<def>
<p>integrin linked kinase</p>
</def>
</def-item>
<def-item>
<term id="G43-fcell.2021.786758">
<bold>IRM</bold>
</term>
<def>
<p>interference reflection microscopy</p>
</def>
</def-item>
<def-item>
<term id="G44-fcell.2021.786758">
<bold>ITGA6</bold>
</term>
<def>
<p>integrin subunit &#x3b1;6</p>
</def>
</def-item>
<def-item>
<term id="G45-fcell.2021.786758">
<bold>ITGB4</bold>
</term>
<def>
<p>integrin subunit &#x3b2;4</p>
</def>
</def-item>
<def-item>
<term id="G46-fcell.2021.786758">
<bold>ITGB5</bold>
</term>
<def>
<p>integrin subunit &#x3b2;5</p>
</def>
</def-item>
<def-item>
<term id="G47-fcell.2021.786758">
<bold>KRT-5</bold>
</term>
<def>
<p>keratin 5</p>
</def>
</def-item>
<def-item>
<term id="G48-fcell.2021.786758">
<bold>KRT-14</bold>
</term>
<def>
<p>keratin&#x20;14</p>
</def>
</def-item>
<def-item>
<term id="G49-fcell.2021.786758">
<bold>LAMA3</bold>
</term>
<def>
<p>laminin subunit &#x3b1;3</p>
</def>
</def-item>
<def-item>
<term id="G50-fcell.2021.786758">
<bold>LAMB3</bold>
</term>
<def>
<p>laminin subunit &#x3b2;3</p>
</def>
</def-item>
<def-item>
<term id="G51-fcell.2021.786758">
<bold>LAMC2</bold>
</term>
<def>
<p>laminin subunit &#x3b3;2</p>
</def>
</def-item>
<def-item>
<term id="G52-fcell.2021.786758">
<bold>MMC</bold>
</term>
<def>
<p>mitomycin C</p>
</def>
</def-item>
<def-item>
<term id="G53-fcell.2021.786758">
<bold>MS</bold>
</term>
<def>
<p>mass spectrometry</p>
</def>
</def-item>
<def-item>
<term id="G54-fcell.2021.786758">
<bold>MTT</bold>
</term>
<def>
<p>3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)</p>
</def>
</def-item>
<def-item>
<term id="G55-fcell.2021.786758">
<bold>NUMA1</bold>
</term>
<def>
<p>nuclear mitotic apparatus protein&#x20;1</p>
</def>
</def-item>
<def-item>
<term id="G56-fcell.2021.786758">
<bold>NUP153</bold>
</term>
<def>
<p>nucleoporin&#x20;153</p>
</def>
</def-item>
<def-item>
<term id="G57-fcell.2021.786758">
<bold>PBS</bold>
</term>
<def>
<p>phosphate-buffered saline</p>
</def>
</def-item>
<def-item>
<term id="G58-fcell.2021.786758">
<bold>PKP1/2/3</bold>
</term>
<def>
<p>plakophilins 1/2/3</p>
</def>
</def-item>
<def-item>
<term id="G59-fcell.2021.786758">
<bold>PLAK</bold>
</term>
<def>
<p>junction plakoglobin</p>
</def>
</def-item>
<def-item>
<term id="G60-fcell.2021.786758">
<bold>PLEC</bold>
</term>
<def>
<p>plectin</p>
</def>
</def-item>
<def-item>
<term id="G61-fcell.2021.786758">
<bold>PPL</bold>
</term>
<def>
<p>periplakin</p>
</def>
</def-item>
<def-item>
<term id="G62-fcell.2021.786758">
<bold>PTX</bold>
</term>
<def>
<p>paclitaxel</p>
</def>
</def-item>
<def-item>
<term id="G63-fcell.2021.786758">
<bold>MT</bold>
</term>
<def>
<p>microtubule</p>
</def>
</def-item>
<def-item>
<term id="G64-fcell.2021.786758">
<bold>PPI network</bold>
</term>
<def>
<p>protein-protein interaction network</p>
</def>
</def-item>
<def-item>
<term id="G65-fcell.2021.786758">
<bold>RPL</bold>
</term>
<def>
<p>ribosomal protein&#x20;large</p>
</def>
</def-item>
<def-item>
<term id="G66-fcell.2021.786758">
<bold>RPS</bold>
</term>
<def>
<p>ribosomal protein&#x20;small</p>
</def>
</def-item>
<def-item>
<term id="G67-fcell.2021.786758">
<bold>SDS-PAGE</bold>
</term>
<def>
<p>sodium dodecyl sulphate-polyacrylamide-gel electrophoresis</p>
</def>
</def-item>
<def-item>
<term id="G68-fcell.2021.786758">
<bold>Src</bold>
</term>
<def>
<p>nonreceptor tyrosin kinase&#x20;Src</p>
</def>
</def-item>
<def-item>
<term id="G69-fcell.2021.786758">
<bold>TEM</bold>
</term>
<def>
<p>transmission electron microscopy</p>
</def>
</def-item>
<def-item>
<term id="G70-fcell.2021.786758">
<bold>TGFBI</bold>
</term>
<def>
<p>transforming growth factor beta induced</p>
</def>
</def-item>
<def-item>
<term id="G71-fcell.2021.786758">
<bold>TGF-&#x3b2;</bold>
</term>
<def>
<p>transforming growth factor &#x3b2;</p>
</def>
</def-item>
<def-item>
<term id="G72-fcell.2021.786758">
<bold>THBS1</bold>
</term>
<def>
<p>thrombospondin-1</p>
</def>
</def-item>
<def-item>
<term id="G73-fcell.2021.786758">
<bold>TLN1</bold>
</term>
<def>
<p>talin 1</p>
</def>
</def-item>
<def-item>
<term id="G74-fcell.2021.786758">
<bold>TLN2</bold>
</term>
<def>
<p>talin 2</p>
</def>
</def-item>
<def-item>
<term id="G75-fcell.2021.786758">
<bold>TNC</bold>
</term>
<def>
<p>tenascin C</p>
</def>
</def-item>
<def-item>
<term id="G76-fcell.2021.786758">
<bold>VCL</bold>
</term>
<def>
<p>vinculin</p>
</def>
</def-item>
<def-item>
<term id="G77-fcell.2021.786758">
<bold>VCR</bold>
</term>
<def>
<p>vincristine</p>
</def>
</def-item>
<def-item>
<term id="G78-fcell.2021.786758">
<bold>VTN</bold>
</term>
<def>
<p>vitronectin</p>
</def>
</def-item>
<def-item>
<term id="G79-fcell.2021.786758">
<bold>WB</bold>
</term>
<def>
<p>Western blot</p>
</def>
</def-item>
</def-list>
</sec>
</back>
</article>